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ABSTRACT

Quinones are the metabolites of a class of chemicals known as polycyclic
aromatic hydrocarbons. These chemicals have been found to be toxic in the environment,
especially when interacting with certain proteins. In this study, we investigated the
modification of Lysozyme and Ribonuclease A by a series of benzoquinones as well as
few naphthoquinones. Fluorescence spectroscopy was used to measure the degree of
modification of Lysozyme and Ribonuclease A when incubated with quinones at
differing concentrations and for various times. All reactions, unless noted, were carried
out in a phosphate buffer (pH=7.0) at 37°C to mimic physiological conditions. The
fluorescence intensity of modified protein was shown to be less than that of unmodified
protein, and effects of quinone substituents were examined. UV-VIS spectroscopy was
also utilized to monitor adduct formation and other protein modifications. This study
adds to our understanding of the effects of quinones on biological systems.
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CHAPTER 1
INTRODUCTION

1

1.1 A Brief Description of Quinones

Quinones are six-membered carbon rings with two carbon-oxygen double bonds
and two carbon-carbon double bonds within the ring itself. Examples of quinones used in
this research are shown below in Figure 1.1.

Figure 1.1

Quinones used in this research (1,4-benzoquinone (PBQ), 2-chloro-1,4benzoquinone (CBQ), 2-methyl-1,4-benzoquinone (MBQ))

Quinones may originate from polycyclic aromatic hydrocarbons (PAHs) and
exhibit toxic behavior in many ways [Snyder et al., 1989; Snyder & Hedli, 1996; Huff et
al., 1989; Cornwell et al., 2003]. For example, quinones can exhibit their toxicity
through redox cycling, adduct formation, and/or inducing enzyme polymerization [Kim et
al., 2012; Kim et al., 2015]. Redox cycling is initiated by quinone reduction by a
reductase, which then is followed by oxidation by molecular oxygen. Adduct formation
is the process of quinone attacking and attaching covalently to a protein. Quinones can
also act as a link between proteins leading to protein oligomerization and polymerization.
In the body, quinones are highly reactive and can cause damage to healthy cells through
DNA modification, lipid modification, and, the focus of this study, protein modification
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[Kim et al. 2012; Vaughn, 2013; Bolton et al., 2000; Batra et al., 2006; Kim, 2013;
Snyder et al., 1989].
Quinones used in this research are listed as follows: 1,4-benzoquinone (PBQ), 2methyl-1,4-benzoquinone (MBQ), 2-chloro-1,4-benzoquinone (CBQ), tetrachloro-1,4benzoquinone (TCBQ), phenyl-1,4-benzoquinone (PhBQ), 2-hydroxy-1,4naphthoquinone (HNQ), 1,2-naphthoquinone (ONQ), and 1,4-naphthoquinone (PNQ).
These quinones were selected due to the different electronic effects and various
modifications they can produce when incubated with protein. For example, some
quinone substituents exhibited greater electron donating effects versus electron
withdrawing effects. This difference led to varying degrees of protein modification with
electron withdrawing effects causing the most modification. Other differences between
quinones were differences in consistency, color, and solubility. All quinones mentioned
above were incubated with Lysozyme while only HNQ was incubated with Ribonuclease
A.

1.2 Background Information on Proteins and Methods Used

Polycyclic aromatic hydrocarbons and their metabolites can specifically lead to
protein aggregation. Studying PAH metabolites is interesting due to recent findings of
the observed protein modifications to Ribonuclease A induced by PBQ as presented in
Figure 1.2 [Kim et al., 2012; Kim et al., 2015].

3

Figure 1.2

Fluorescence spectra of RNase A (0.050 mM) and RNase A (0.050 mM)
modified by PBQ (0.050, 0.25, 0.50, or 1.50 mM) [Kim et al., 2012].

When proteins begin to aggregate, the result can disrupt encoding pathways
leading to improper function of the cells. Protein aggregation occurs naturally as one
gets older, and sometimes is the cause of Alzheimer’s, Parkinson’s, or Huntington’s
disease [Bemporad et al., 2006; Chiti & Dobson, 2006; Chiti & Dobson, 2009; Dobson,
2003; Ramirez-Alvarado, 2008; Gregersen et al., 2006]. It can easily be understood how
mature protein aggregation can be toxic; however, recent research has shown that
immature protein aggregations are much more toxic [Zhu et al., 2000; Nilsberth et al.,
2001]. In this research, the interaction between a variety of quinones and two wellstudied proteins, Lysozyme and Ribonuclease A, is investigated and quantified by use of
fluorescence and UV-VIS spectroscopy.
Lysozyme is a model protein in biochemical research due to its relatively small
size and ability to form crystals which are easy to manipulate [Swaminathan et al., 2011].
The function of Lysozyme is to hydrolyze glycosidic bonds between N-acetylmuramic
acid and N-acetylglucosamine in Gram-positive bacteria, essentially acting as an
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antibacterial agent [Willey et al., 2011]. Lysozyme was chosen for these studies due to
its similar characteristics to proteins that have been found linked to neurodegenerative
diseases. Specifically, Lysozyme is an amyloidogenic protein which makes it useful for
comparison and understanding of such proteins that can generate plaques which cause
bodily harm. In addition, Lysozyme exhibits good fluorescence behavior made possible
by tyrosine and tryptophan residues which make up the protein.
Ribonuclease A is a model protein in biochemical research similar in size and
crystal formation to Lysozyme. The function of Ribonuclease A is to degrade RNA
strands into smaller parts. With a high affinity for single strand RNA, Ribonuclease A
can exhibit its nuclease behavior both as an endonuclease and exonuclease [Voet et al.,
2012]. Since Ribonuclease A is extremely common in our bodies and in the
environment, it is an excellent protein to use in measuring the modification by other
potentially harmful agents in the environment. In comparison with Lysozyme,
Ribonuclease A is a non-amyloidogenic protein and therefore does not produce harmful
plaques upon alteration of the protein structure. Though Ribonuclease A exhibits less
fluorescence behavior than Lysozyme due to the absence of tryptophan, excess tyrosine
residues contribute to the overall fluorescence behavior of the molecule.
Fluorescence spectroscopy is an analytical spectroscopic technique used to
measure the fluorescence behavior of certain molecules at a highly sensitive level. Upon
radiation with incident light, molecules absorb energy when their electrons are excited to
higher energy levels and release energy when their electrons return to a more stable state.
This process is known as fluorescence and can be used to identify molecules in addition
to measuring changes molecules undergo [Skoog et al., 2007]. In this research, the
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fluorescence behavior of proteins was measured to gain insight on the potential degree of
modification caused by exposure to quinone molecules. The fluorescence of pure protein
was compared with the fluorescence of altered protein as result of quinone molecules
performing modification. Since both proteins used in this study contained amino acid
residues with high quantum yields (tryptophan and tyrosine), the fluorescence behavior of
the protein was dominated by these amino acids. It is believed any alteration to the
fluorescence behavior of protein upon incubation with quinone is result of some
structural change to the protein or an addition of quinone to the protein. This
modification of protein affects the amino acid residues responsible for fluorescence, and
ultimately cause a change in the fluorescence behavior of the protein.
UV-VIS spectroscopy is an analytical spectroscopic technique used to measure
the absorbance of certain molecules in the UV-VIS region of the electromagnetic
spectrum. Upon radiation with incident light, molecules absorb energy as their electrons
are excited to higher energy levels and it is this absorbance that is measured with UVVIS spectroscopy [Skoog et al., 2007]. Similar to fluorescence, certain amino acid
residues, such as tryptophan and tyrosine, dominate in regard to the ability of absorbing
energy. Due to UV-VIS spectroscopy being a technique of measuring absorbance, any
addition of molecules that absorb in the UV-VIS range will affect the overall absorbance
of the original molecule before addition of other molecules. It is believed that the
addition of quinone to the proteins used in this study increases the absorbance of the
modified protein because of covalently attached quinone molecules which, by
themselves, absorb highly in the UV-VIS range.
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1.3 Prior Studies in Our Lab

Much research has been performed at UTC over the past several years regarding
Lysozyme, Ribonuclease A, and quinones. The results of these studies have paved the
way for the understanding of the results presented in Chapters 2 and 3. Previous research
has centered around the modification of protein specifically through protein crosslinking
which results in protein oligomerization. This modification has been verified mainly
through use of SDS-PAGE with fluorescence and UV-VIS spectroscopy as supporting
analytical techniques. Several prior studies have utilized SDS-PAGE gels which support
the results collected through this study. In this chapter, results from previous studies will
be presented and discussed.

1.3.1

Modifications of ribonuclease A induced by p-benzoquinone
In these studies carried out by Kim et al., Ribonuclease A modifications were

investigated upon exposure to PBQ at various concentrations [Kim et al., 2012].
Ribonuclease A was fixed at a concentration of 0.050 mM with PBQ used at 0.050, 0.25,
0.50, or 1.50 mM. Fluorescence spectroscopy along with UV-VIS spectroscopy was
utilized to examine the spectrophotometric characteristics of Ribonuclease A after
exposure to PBQ in addition to unmodified Ribonuclease A. SDS-PAGE was also
utilized to visualize polymeric aggregates formed by the various reactions. All studies
were performed using a phosphate buffer (50 mM) at pH=7.0 and 37°C.
The major findings of these studies are straight forward, PBQ does elicit
modification of Ribonuclease A by forming both Ribonuclease A adducts and polymeric
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aggregates. Figure 1.3 shows corresponding graphs of fluorescence and UV-VIS spectra
of Ribonuclease A incubated with PBQ [Kim et al., 2012].

Figure 1.3

(A) Fluorescence and (B) UV-VIS spectra of RNase A (0.050 mM) and
modified RNase A by PBQ (0.050, 0.25, 0.50, or 1.5 mM) for 24 h at
37°C [Kim et al., 2012].

The fluorescence behavior of modified Ribonuclease A is found to be less than
unmodified Ribonuclease A indicating PBQ does elicit detectable modifications of
Ribonuclease A. In addition, UV-VIS studies indicate PBQ formed covalent bonds to the
modified Ribonuclease A supporting adduct formation induced by PBQ. As seen in
Figure 1.4, SDS-PAGE results show PBQ is efficient in producing oligomers over time
by observing the results of previously performed reactions involving PBQ and
Ribonuclease A [Kim et al., 2012].
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Figure 1.4

Concentration and time-dependent modification of RNase A upon
exposure to PBQ at 0.50 mM and 5.0 mM in phosphate buffer (pH=7.0, 50
mM) at 37°C [Kim et al., 2012].

Overall, these results show PBQ can induce formation of both Ribonuclease A
adducts and aggregates.
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1.3.2

A comparison study on ribonuclease A modifications
induced by substituted p-benzoquinones
In these studies carried out by Kim et al., Ribonuclease A modifications were

investigated upon exposure to PBQ, MBQ, or CBQ [Kim et al., 2015]. Fluorescence
spectroscopy along with UV-VIS spectroscopy was utilized to examine the
spectrophotometric characteristics of Ribonuclease A after exposure to PBQ, MBQ,
CBQ, and unmodified Ribonuclease A. SDS-PAGE was also utilized to visualize
polymeric aggregates formed by the various reactions using each quinone. In SDSPAGE experiments, Ribonuclease A was fixed at a concentration of 0.145 mM with each
quinone used at 1.0 mM. All studies were performed using a phosphate buffer (50 mM)
at pH=7.0 and 37°C.
As with previous studies, each quinone elicited modification of Ribonuclease A
by forming polymeric aggregates and adducts. From these studies, it was found each
quinone caused varying degrees of modification when incubated for the same amount of
time. As seen in Figure 1.5, the fluorescence behavior of modified Ribonuclease A is
found to be less than unmodified Ribonuclease A indicating that all quinones elicit
modification of Ribonuclease A [Kim et al., 2015]. In addition, UV-VIS studies indicate
all quinones covalently bond to Ribonuclease A supporting the previously described
pathway of modification through adduct formation. As seen in Figure 1.6, SDS-PAGE
results show all quinones modify Ribonuclease A through oligomerization [Kim et al.,
2015]. CBQ was found to cause the quickest and most pronounced degree of
modification and MBQ was found to cause the least degree of modification.
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Overall, these studies show an order of increasing reactivity towards
Ribonuclease A beginning with MBQ causing the least modification, PBQ causing an
intermediate level of modification, and CBQ causing the greatest modification.

Figure 1.5

(A) Fluorescence and (B) UV-VIS spectra of RNase A (0.050 mM) and
modified RNase A by PBQ, CBQ, or MBQ (0.50 mM) for 24 h at 37°C
[Kim et al., 2015].

Figure 1.6

Time-dependent modification of RNase A (0.145 mM) treated with MBQ,
PBQ, or CBQ (1.0 mM) for 1, 2, 3, 4 ,5 h at 37°C in phosphate buffer
(pH=7.0, 50 mM). MM, protein standard molecular marker; U, RNase A;
(A) RNase A + MBQ; (B) RNase A + PBQ; (C) RNase A + CBQ [Kim et
al., 2015].
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1.3.3

Modifications of Lysozyme by Substituted Benzoquinones
In these studies carried out by Greve & Kim presented in a Departmental Honors

Thesis at UTC, Lysozyme modifications were investigated upon exposure to PBQ, CBQ,
or MBQ [Greve & Kim, 2015]. SDS-PAGE was used to verify any modification of
Lysozyme through induction of polymeric aggregation by PBQ, CBQ, or MBQ.
Lysozyme was fixed at a concentration of 0.10 mM with quinones used at 0.10, 0.50, 1.0,
and 3.0 mM. All studies were performed using a phosphate buffer (50 mM) at pH=7.0
and 37°C.
Due to the similarities of Lysozyme to Ribonuclease A, similar results were
achieved regarding protein modification by PBQ, CBQ, and MBQ. Specifically, the
amount of polymeric aggregate formation formed by CBQ opposed to PBQ and MBQ.
In addition, aggregate formation was found to be decreasing with respect to decreasing
concentration of quinone. This result was true for all quinones with the only difference
being the degree of oligomerization each quinone was responsible for inducing. Figures
1.7 through 1.10 show PBQ elicits intermediate modification of Lysozyme through
protein oligomerization leading to polymeric aggregation [Greve & Kim, 2015]. As seen
in Figures 1.11 through 1.14, CBQ, having electron withdrawing properties, favors
interaction with nucleophilic amino acid residues from Lysozyme and induces protein
oligomerization [Greve & Kim, 2015]. However, as seen in Figures 1.15 through 1.18,
the studies performed with MBQ showed little polymeric aggregation compared to PBQ
and MBQ and suggest MBQ, having electron donating properties, does not produce
significant modifications to Lysozyme [Greve & Kim, 2015].
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Overall, SDS-PAGE studies show dimer, trimer, and polymeric aggregate
formation across all reactions involving quinones and Lysozyme. Concentration of
quinone plays an important role in determining the degree of protein crosslinking along
with the length of incubation. Similar to previous studies performed by Kim et al., CBQ
elicits the greatest modification of Lysozyme, PBQ elicits intermediate modification of
Lysozyme, and MBQ elicits the least modification of Lysozyme [Kim et al., 2015].

Figure 1.7

Time-dependent modification of Lyz (0.10 mM) treated with PBQ (3.0
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate
buffer (pH=7.0, 50 mM). MM, molecular marker; L1, Lyz (0.10 mM);
L2-L8, Lyz + PBQ (3.0 mM) 10-300 min, L9, Lyz + PBQ (3.0 mM) 24 h
[Greve & Kim, 2015].
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Figure 1.8

Time-dependent modification of Lyz (0.10 mM) treated with PBQ (1.0
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate
buffer (pH=7.0, 50 mM). MM, molecular marker; L1, Lyz (0.10 mM);
L2-L8, Lyz + PBQ (1.0 mM) 10-300 min, L9, Lyz + PBQ (1.0 mM) 24 h
[Greve & Kim, 2015].

Figure 1.9

Time-dependent modification of Lyz (0.10 mM) treated with PBQ (0.50
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate
buffer (pH=7.0, 50 mM). MM, molecular marker; L1, Lyz (0.10 mM);
L2-L8, Lyz + PBQ (0.50 mM) 10-300 min, L9, Lyz + PBQ (0.50 mM) 24
h [Greve & Kim, 2015].
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Figure 1.10

Time-dependent modification of Lyz (0.10 mM) treated with PBQ (0.10
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate
buffer (pH=7.0, 50 mM). MM, molecular marker; L1, Lyz (0.10 mM);
L2-L8, Lyz + PBQ (0.10 mM) 10-300 min, L9, Lyz + PBQ (0.10 mM) 24
h [Greve & Kim, 2015].

Figure 1.11

Time-dependent modification of Lyz (0.10 mM) treated with CBQ (3.0
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate
buffer (pH=7.0, 50 mM). MM, molecular marker; L1, Lyz (0.10 mM);
L2-L8, Lyz + CBQ (3.0 mM) 10-300 min, L9, Lyz + CBQ (3.0 mM) 24 h
[Greve & Kim, 2015].
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Figure 1.12

Time-dependent modification of Lyz (0.10 mM) treated with CBQ (1.0
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate
buffer (pH=7.0, 50 mM). MM, molecular marker; L1, Lyz (0.10 mM);
L2-L8, Lyz + CBQ (1.0 mM) 10-300 min, L9, Lyz + CBQ (1.0 mM) 24 h
[Greve & Kim, 2015].

Figure 1.13

Time-dependent modification of Lyz (0.10 mM) treated with CBQ (0.50
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate
buffer (pH=7.0, 50 mM). MM, molecular marker; L1, Lyz (0.10 mM);
L2-L8, Lyz + CBQ (0.50 mM) 10-300 min, L9, Lyz + CBQ (0.50 mM) 24
h [Greve & Kim, 2015].
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Figure 1.14

Time-dependent modification of Lyz (0.10 mM) treated with CBQ (0.10
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate
buffer (pH=7.0, 50 mM). MM, molecular marker; L1, Lyz (0.10 mM);
L2-L8, Lyz + CBQ (0.10 mM) 10-300 min, L9, Lyz + CBQ (0.10 mM) 24
h [Greve & Kim, 2015].

Figure 1.15

Time-dependent modification of Lyz (0.10 mM) treated with MBQ (3.0
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate
buffer (pH=7.0, 50 mM). MM, molecular marker; L1, Lyz (0.10 mM);
L2-L8, Lyz + MBQ (3.0 mM) 10-300 min, L9, Lyz + MBQ (3.0 mM) 24
h [Greve & Kim, 2015].
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Figure 1.16

Time-dependent modification of Lyz (0.10 mM) treated with MBQ (1.0
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate
buffer (pH=7.0, 50 mM). MM, molecular marker; L1, Lyz (0.10 mM);
L2-L8, Lyz + MBQ (1.0 mM) 10-300 min, L9, Lyz + MBQ (1.0 mM) 24
h [Greve & Kim, 2015].

Figure 1.17

Time-dependent modification of Lyz (0.10 mM) treated with MBQ (0.50
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate
buffer (pH=7.0, 50 mM). MM, molecular marker; L1, Lyz (0.10 mM);
L2-L8, Lyz + MBQ (0.50 mM) 10-300 min, L9, Lyz + MBQ (0.50 mM)
24 h [Greve & Kim, 2015].
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Figure 1.18

Time-dependent modification of Lyz (0.10 mM) treated with MBQ (0.10
mM) for 10, 30, 60, 120, 180, 240, and 300 min at 37°C in phosphate
buffer (pH=7.0, 50 mM). MM, molecular marker; L1, Lyz (0.10 mM);
L2-L8, Lyz + MBQ (0.10 mM) 10-300 min, L9, Lyz + MBQ (0.10 mM)
24 h [Greve & Kim, 2015].
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1.3.4

Ribonuclease A Modification Induced by 1,2-Naphthoquinone and
2-Hydroxy-1,4-Naphthoquinone
In these studies carried out by Smith & Kim presented in a Departmental Honors

Thesis at UTC, Ribonuclease A modifications were investigated upon exposure to ONQ
and HNQ [Smith & Kim, 2015]. Ribonuclease A was fixed at a concentration of 0.10
mM with naphthoquinones used at 5.0 mM. SDS-PAGE was primarily used to examine
the modification of Ribonuclease A through protein oligomerization induced by ONQ or
HNQ. Reactions with Ribonuclease A were performed at pH=7.0 and 37°C to mimic
physiological conditions. In addition, to fully understand the effects of each
naphthoquinone on Ribonuclease A, the incubation conditions of Ribonuclease A were
varied regarding pH. Considering HNQ, specifically the ionizable hydroxyl group,
changes in the pH of the incubation condition would supposedly alter the functionality of
both Ribonuclease A and HNQ.
As seen in Figure 1.19, SDS-PAGE results show ONQ to elicit greater activity
towards Ribonuclease A resulting in protein oligomerization [Smith & Kim, 2015]. As
seen in Figures 1.20 and 1.21, HNQ, regardless of pH change, was not found to cause
protein oligomerization and was believed to carry out its protein modifying capabilities
through other mechanisms [Smith & Kim, 2015]. It is these mechanisms that are
investigated and discussed more in Chapter 3.
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Figure 1.19

Time-dependent modification of RNase A (0.10 mM) treated with ONQ
(5.0 mM) for 10 min, 30 min, 1, 2, 3, and 24 h at 37°C in phosphate buffer
(pH=7.0, 50 mM). L1, RNase A (0.10 mM), L2-L7, RNase A + ONQ (5.0
mM) 30 min-24 h, L8, molecular marker [Smith & Kim, 2015].

Figure 1.20

Time-dependent modification of RNase A (0.10 mM) treated with HNQ
(5.0 mM) for 10 min, 30 min, 1, 2, 3, and 24 h at 37°C in phosphate buffer
(pH=7.0, 50 mM). L1, RNase A (0.10 mM), L2-L7, RNase A + HNQ (5.0
mM) 30 min-24 h, L8, molecular marker [Smith & Kim, 2015].
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Figure 1.21

Time-dependent modification of RNase A (0.10 mM) treated with HNQ
(5.0 mM) for 10 min, 30 min, 1, 2, 3, and 24 h at 37°C in phosphate buffer
(pH=4.8, 50 mM). L1, RNase A (0.10 mM), L2-L7, RNase A + HNQ (5.0
mM) 30 min-24 h, L8, molecular marker [Smith & Kim, 2015].
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CHAPTER 2
STUDIES OF LYSOZYME MODIFICATIONS INDUCED BY QUINONES
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2.1 Introduction

In previous studies performed by Greve & Kim, certain quinones have been found
to induce modification of Lysozyme [Greve & Kim, 2015]. So far, PBQ, MBQ, and
CBQ have all been found to elicit modification of Lysozyme through protein
crosslinking, which yields protein oligomerization, and adduct formation. This current
study seeks to add to previous studies regarding the quinones mentioned above, as well as
test several others on their modifying capabilities towards Lysozyme. Additional
quinones include: TCBQ, PhBQ, HNQ, ONQ, and PNQ. In addition, certain parameters
such as pH and temperature are altered to investigate their effects on the modification of
Lysozyme incubated with PBQ. Fluorescence and UV-VIS spectroscopy were used to
examine the modifications of Lysozyme induced by these quinones.

2.2 Methodology

All chemicals were purchased from Sigma Aldrich, Fisher, Acros Organics, or
MP Biomedicals and were of reagent grade. The protein of interest, Lysozyme (from
hen egg white), was purchased from MP Biomedicals and kept frozen for preservation
until ready for use. All water used in this study was deionized (DI) water purified by a
Millipore system (Milli-Q). All solutions were made in lab and kept sealed or covered
until ready for use. All reactions were performed in a similar manner following the
devised experimental protocol to keep error at a minimum. Each study was performed
over a three-day period consisting of (1) preparing and starting the reaction, (2)
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performing dialysis of the incubated solution, and (3) finishing the reaction. Quartz
cuvettes, purchased from Starna Cells, Inc., were re-used after being thoroughly cleaned
with Starna Cells, Inc. cuvette cleaner and allowed to dry. At times, when higher
concentration reactions were performed, a film-like residue would build up on the inside
of the reaction cuvette. This was cleaned by filling to the brim with concentrated nitric
acid and allowed to soak overnight. The next day, the normal cleaning procedure with
cuvette cleaner was performed to ensure a thorough cleaning of the cuvette.
Physiological conditions (pH=7.0, 37°C) were modeled for all reactions except for
studies in which the pH or temperature was varied. At all times, proper laboratory
protocol was followed and the laboratory was kept in clean and functional condition.

2.2.1

Buffer Solution
A phosphate buffer (50 mM), comprised of a mixture of monobasic monosodium

phosphate crystal (NaH2PO4·H2O) and dibasic disodium phosphate anhydrous
(Na2HPO4), was prepared and used for all reactions in this study. Most reactions were
performed at pH=7.0 and 37°C to mimic physiological conditions. However, some
reactions were performed at a different pH or temperature to study the effect of changing
these factors. The phosphate buffer solution was used in every 3 mL reaction cuvette as
well as in 1 L beakers when performing dialysis. Solutions of NaH2PO4·H2O (50 mM)
and Na2HPO4 (50mM) were combined in ratios to produce a solution at a pH predetermined by the Henderson-Hasselbalch equation (Eq. 2.1).
[𝑏𝑎𝑠𝑒]

𝑝𝐻 = 𝑝𝐾𝑎 + 𝑙𝑜𝑔 [𝑎𝑐𝑖𝑑]
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(Eq. 2.1)

A phosphate buffer solution was chosen primarily because of the multiple
dissociation constants of phosphoric acid. Since the second deprotonation of phosphoric
acid has a pKa around 7.2, an equilibrium between NaH2PO4·H2O and Na2HPO4 creates
an effective buffering range around pH=7.0. Due to the physiological approach of the
study, the use of phosphates in the buffer solution keeps the study in line with biological
systems.
To perform a reaction, 4 L of buffer was made fresh the day before each reaction.
14.19 g of Na2HPO4 (50mM) was weighed and carefully poured in a 2 L volumetric flask
followed by dilution to the line with deionized water. Following the same procedure,
13.79 g of NaH2PO4·H2O (50 mM) was weighed and carefully poured in a similar 2 L
volumetric flask, again diluting to the line with deionized water. To have enough
Na2HPO4 (50mM) for pH=7.0, an additional 0.500 L of Na2HPO4 (50mM) was made by
weighing 3.55 g of Na2HPO4 (50mM) and following the same dilution and mixing
protocol mentioned above. These flasks were subjected to stirring by mechanical means
for roughly 30 min. Once fully dissolved, the two solutions of acid and base were
combined in pre-determined ratios, 1 L at a time, to produce the desired pH of the buffer.
For example, for a buffer solution at pH=7.0, 557 mL of Na2HPO4 (50 mM) was
combined with 443 mL of NaH2PO4·H2O (50 mM), adequately mixed, and transferred
into a 4 L plastic jug. This process was repeated three additional times to produce 4 L of
buffer solution. The final pH of solution was checked using a Fisher AB15 Accumet pH
meter equipped with an AccuTupH probe. After calibration with stock solutions at
pH=4.00 and pH=10.01, if the pH of the buffer solution was within ± 0.05 units of the
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desired pH, the solution was acceptable and was stored in the fridge at 4°C until ready for
use.

2.2.2

Protein Solution
Lysozyme stock solutions were made to provide enough protein for the extent of

this study. This involved carefully weighing an imprecise amount of Lysozyme, 0.0462
g, onto tared weigh-paper and quantitatively transferring into a 10 mL volumetric flask.
Phosphate buffer (50 mM, pH=7.0) was used to wash any residual Lysozyme off the
weigh-paper into the volumetric flask. Lysozyme, in the volumetric flask, was diluted to
the line with phosphate buffer (50 mM, pH=7.0) and the flask was capped and sealed
with ParaFilm. To facilitate the protein into solution, sonication was performed for 15
min in addition to inversion and shaking the volumetric flask by hand. After sonication,
the protein solution was carefully transferred to Eppendorf tubes and stored in the freezer
until needed.
The concentration of stock Lysozyme was calculated by converting 0.0462 g of
Lysozyme to moles of Lysozyme and then dividing by 0.0100 L. To convert grams to
moles, 0.0462 g of Lysozyme was divided by 14388 g/mol, the molecular weight of
Lysozyme. This value was then divided by 0.0100 L to determine the molarity, or
concentration, of the stock Lysozyme. Finally, this concentration was multiplied by 1000
to express the concentration in mM, a unit easier to manipulate during future calculations.
As result, the concentration of stock Lysozyme was determined to be 0.321 mM.
To perform a reaction, one Eppendorf tube containing the stock Lysozyme was
retrieved from the freezer and allowed to thaw out on ice for 20 min, on the counter for
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20 min, and finally in the hand for a few minutes. Once completely thawed, the protein
solution was vortexed for 1 min to ensure homogeneity before being ready for use.
For all studies involving the modification of Lysozyme by quinones, Lysozyme
was fixed at a concentration of 0.010 mM. Calculations were performed to determine the
exact volume of stock Lysozyme to add to each reaction cuvette to obtain a Lysozyme
concentration of 0.010 mM. This was performed using Equation 2.2 where M1 is the
concentration of stock Lysozyme (0.321 mM), V1 is the required aliquot of stock
Lysozyme to be added to the reaction cuvette, M2 is the desired concentration of
Lysozyme (0.010 mM), and V2 is the desired volume in the reaction cuvette (3000 μL).
𝑀1 𝑉1 = 𝑀2 𝑉2

(Eq. 2.2)

As result, 93.5 μL of stock Lysozyme was transferred to a 3 mL reaction cuvette
containing phosphate buffer (50 mM) to achieve a Lysozyme concentration of 0.010 mM
used for all studies.

2.2.3

Quinone Solution
Quinone solutions were made fresh for every reaction performed. This involved

weighing an imprecise amount of quinone on tared weigh-paper (a mass between 0.0100
g and 0.0200 g) and quantitatively transferring to a 10 mL, 50 mL, or even 100 mL
volumetric flask. Phosphate buffer (50 mM) was used to wash any residual quinone off
the weigh-paper into the volumetric flask. Quinone, in the volumetric flask, was diluted
to the line with phosphate buffer (50 mM) and capped and sealed with ParaFilm. To
facilitate the quinone into solution, sonication was performed for 10 min in addition to
inversion and shaking the volumetric flask by hand. Halfway through the sonication
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procedure, the volumetric flask was removed, inverted to mix the solution, and then
placed back into the sonicator. After sonication, the quinone solution was transferred
into a small holding beaker, covered with foil, and was ready for use.
Considering the quinones used, PBQ dissolved easily into solution with the
techniques mentioned above, but MBQ, CBQ, TCBQ, PhBQ, HNQ, ONQ, and PNQ
required an additional agent to aide with their solubility. For this, a 10% MeOH/90%
phosphate buffer (50 mM) was used to help dissolve the quinones in the 10 mL, 50 mL,
or 100 mL volumetric flasks. It is important to note only the volumetric flask containing
the quinone solution contained 10% MeOH. Once the quinone, in solution, was
transferred from the small holding beaker to the reaction cuvette, phosphate buffer (50
mM) was used to bring the reaction cuvette up to volume. When using the 10%
MeOH/90% phosphate buffer solution for quinone preparation, the overall concentration
of MeOH in the reaction cuvettes never exceeded 1%.
During the sonication procedure, the concentration of quinone prepared in
solution was calculated by converting the mass of quinone to moles of quinone and then
dividing by the volume of the volumetric flask the quinone was dissolved in. To convert
grams of quinone to moles of quinone, the mass of quinone was divided by the molar
mass of the quinone. This value was then divided by the volume of the volumetric flask
used to determine the molarity, or concentration, of the quinone in solution. Finally, this
concentration was multiplied by 1000 to express the concentration in mM, a unit easier to
manipulate during future calculations.
In addition, further calculations were performed during the sonication process to
determine the exact volume of quinone solution to add to the reaction cuvette containing
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Lyz (0.010 mM) and phosphate buffer (50 mM) to achieve the desired concentration of
quinone in the reaction cuvette. This was calculated using Equation 2.3 where, in this
case, M1 is the actual concentration of the quinone solution prepared, V1 is the required
aliquot of quinone solution to be added to the reaction cuvette, M2 is the desired
concentration of quinone, and V2 is the desired volume in the reaction cuvette (3000 μL).
𝑀1 𝑉1 = 𝑀2 𝑉2

(Eq. 2.3)

Since several concentrations of quinone were used across all studies, and the
amount of quinone weighed out each time was different, the amount of quinone solution
added to the reaction cuvette varied reaction to reaction.
For PBQ, aliquot volumes were calculated for desired concentrations of 0.010
mM, 0.050 mM, 0.10 mM, and 0.30 mM. For MBQ, CBQ, TCBQ, PhBQ, HNQ, ONQ,
PNQ, and studies involving PBQ at different temperatures or pH, aliquot volumes were
calculated for a fixed concentration of 0.050 mM. This concentration was determined to
work with best when comparing different quinones or variables of reactions because it
provided a concentration high enough to modify Lysozyme significantly.
Once the calculated volume of quinone solution was added to the reaction cuvette
containing Lyz (0.010 mM) and phosphate buffer (50 mM), the reaction began, the
cuvette was placed into the fluorimeter for scanning, and the reaction time was kept on a
scientific timer.
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2.2.4

Fluorescence Spectroscopy & Anisotropy Measurements
Fluorescence spectroscopy was performed using a Horiba Jobin Yvon Fluorolog

spectrophotometer equipped with a Xenon lamp. The excitation wavelength was fixed at
280 nm with a 2 nm slit width to accommodate tryptophan and tyrosine residues in
Lysozyme. The resulting emission was recorded every 1 nm with a slit width of 2 nm
over the range of 290-600 nm. To draw correlations between all studies, each spectrum
was normalized from 500-550 nm where little emission was recorded. Microsoft Excel
was used to analyze the data and to produce graphs to visualize the fluorescence spectra.
All reactions were performed in a quartz cuvette in phosphate buffer (50 mM).
The cuvette was equipped with a stir bar to ensure proper mixing and to minimize
sedimentation of Lysozyme. The stirring motion was set to the 3rd level of power as
indicated on the fluorimeter. Emission scanning lasted around 10 min and varied
occasionally in duration due to mechanical motion inside of the fluorimeter. Initial
scanning, or reaction scanning, of Lysozyme occurred over 24 h with scans occurring
every hour for that duration. Post-modified Lysozyme was returned to a quartz cuvette
after a 24 h dialysis and scanned an additional four times. This resulting data was
recorded, averaged, and analyzed in Microsoft Excel to produce the graphs presented in
this study. A control was produced by subjecting Lyz (0.010 mM) in phosphate buffer
(50 mM) to the same procedure as every reaction performed.
The software to operate the fluorimeter was FluorEssence by Horiba Jobin Yvon.
This software was capable of automating fluorescence and anisotropy scans which were
utilized to accomplish the 24 h scans of each study. The first and second scans were
always started manually with each consecutive scan being automatically started by the
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programming. Since each emission scan lasted around 10 min (600 s), the instrument
was programmed to scan the reaction every 2997 s for 24 h to accomplish 24 h of
scanning each hour. Due to the mechanical motion of parts inside of the fluorimeter, an
additional 3 s was added to accommodate the automated re-calibration of the instrument
after each scan. Due to fluctuations in voltage supplied to the instrument, the timing of
the scans slightly varied for each reaction and occasionally needed to be reset during the
reaction.
The process of performing fluorescence measurements was performed in a similar
manner for every reaction by following a pre-determined protocol. To begin, the
fluorimeter was turned on by first switching on the water bath, the fan, the lamp, and then
the software PC. The lamp was allowed to warm up for 1 h before any measurements
took place. The instrument was initialized by selecting to perform a spectra study,
specifically an emission study, and then by executing a trial scan (C1-Trial) with the
cuvette containing only Lysozyme and phosphate buffer (50 mM). Once the initialization
was complete and the trial scan was acceptable, the software was used to program the
instrument for fluorescence measurements. A scientific timer was obtained and started as
soon as the aliquot of quinone was administered to the reaction cuvette containing
Lysozyme and phosphate buffer. After this, the reaction cuvette was capped, the sides
wiped with Kimwipes, inverted 3 times, and placed in the fluorimeter for scanning. Once
securely positioned inside the fluorimeter, the fluorescence scanning was started and the
time on the scientific timer was recorded. This time was the delay between the actual
start of the reaction of Lysozyme with quinone and the fluorescence scanning of the

32

reaction. In addition, the time of day was recorded to be able to monitor the start and
stop of each consecutive measurement every hour.
Post-modified Lysozyme fluorescence measurements were performed using a
different programmed scanning procedure as initial scanning. In these scans, modified
Lysozyme was scanned four times in the time frame of 1 h at 37°C. Once these scans
were complete, the cuvette was removed from the fluorimeter and the instrument was
shut down in the reverse order in was turned on. This concluded the use of fluorescence
spectroscopy to measure the modification of Lysozyme induced by quinones.
In addition to fluorescence measurements, anisotropy measurements were
performed as well during initial and post-modified scanning of Lysozyme. Appendix A
shows anisotropy measurements for each study performed using Lysozyme. A general
trend can be seen in each graph indicating the correlation between increasing
modification of Lysozyme and increasing anisotropy values of Lysozyme.

2.2.5

UV-VIS Spectroscopy
UV-VIS spectroscopy was performed using a double-beam UV-1800 Shimadzu

UV Spectrophotometer. The instrument was always allowed to warm up for 20 min
before any measurements took place. Excitation was achieved using a D2/W lamp with
the resulting spectra recorded at 1 nm sampling intervals over the range of 200-700 nm
with the scan speed set to fast. The slit width was 1.0 nm and the D2/W light change was
set at 340.8 nm. The instrument was auto-zeroed and baselined prior to every scan to
account for background noise. Microsoft Excel was used to analyze the data recorded
and to produce the graphs presented in this study.
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Immediately after fluorescence scanning was complete, the cuvette was
transferred into the UV-VIS spectrophotometer for analysis. Absorbance of the analyte
was recorded and immediately processed on screen using the software UV Probe 2.33. A
reference cell containing phosphate buffer (50 mM, pH=7.0) was prepared at the
beginning of the study and was used for every reaction throughout the study. This
insured the absorbance calculated by the instrument was solely from Lysozyme and any
bound or unbound quinone. Pre-dialysis Lysozyme exhibited larger absorbance than
post-dialysis Lysozyme due to unbound quinone in solution absorbing light. Removal of
unbound quinone by dialysis reduced the absorbance of the analyte and produced a more
accurate representation of modified Lysozyme.
All UV-VIS measurements were performed in the same manner and used to
measure the amount of modification (by adduct formation) of Lysozyme.

2.2.6

Dialysis
To accurately measure the modification of Lysozyme induced by quinones,

dialysis was performed to remove unbound quinone that was not covalently bonded to
Lysozyme. Spectroscopically measuring Lysozyme with bound quinone alone gives
clear understanding of the modification of Lysozyme induced by quinones.
Dialysis was performed using a 5 mL Float-A-Lyzer purchased from Spectrum
Laboratories. The membrane, with a molecular cutoff of 3.5 kDa, allowed unbound
quinone to freely exit through the membrane. Lysozyme, with a molecular mass of 14.3
kDa, or modified Lysozyme, with a slightly higher molecular mass, remained inside of
the dialysis membrane along with any quinone bound to the protein via ionic bonding,
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covalent bonding, or H-bonding. Before use, each dialysis membrane was thoroughly
soaked, washed, and rinsed with DI water and then temporarily held in phosphate buffer
solution (50 mM) kept at 4°C. Before the reaction solution could be transferred into the
dialysis membrane, the membrane was emptied of phosphate buffer solution to insure
proper concentration of the protein and quinone in solution. Once the reaction solution
was carefully transferred from the reaction cuvette to the dialysis membrane by a
disposable pipette, the dialysis membrane was placed in 900 mL of phosphate buffer
solution and kept at 4°C for 24 h. Facilitation of unbound quinone out of the dialysis
membrane was accelerated by the concentration gradient between the phosphate buffer
solution and the reaction solution as well as by stirring using a stir bar. Since the
concentration of quinone outside of the dialysis membrane was less than the
concentration of quinone inside of the dialysis membrane, simple diffusion occurred and
the unbound quinone exited the dialysis membrane. This was further accelerated by
changing out the phosphate buffer solution three times, typically every 2.5 h. By doing
this, the concentration gradient became smaller each time and diffusion continued to take
place. After three buffer changes, and considering the volume of reaction solution to
phosphate buffer solution, it is safe to assume all unbound quinone had been washed
from the reaction solution.
After 24 h of dialysis, the contents in the dialysis membrane were returned to a
clean reaction cuvette and placed in the fluorimeter for post-dialysis fluorescence
scanning. By removal of unbound quinone in solution, the modification of Lysozyme by
bound quinone only was measured and quantified by fluorescence and UV-VIS
spectroscopy.
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2.3 Results and Discussion

The results of several reactions involving Lysozyme are presented below. Six different
studies were conducted: (1) a study with PBQ at various concentrations, (2) a study with
PBQ incubated for various lengths of time, (3) a study involving certain substituents on
PBQ, (4) a study involving naphthoquinones, and (5-6) studies focused on the pH and
temperature dependence of PBQ. Fluorescence and UV-VIS graphs are included for each
study. The graphs depict the fluorescence intensity and absorbance of post-dialysis
Lysozyme. Post-dialysis Lysozyme (i.e. modified Lysozyme) refers to Lysozyme which
has completed a 24 h dialysis and contains only Lysozyme and any bound quinone to the
protein.
Normalized integrated fluorescence intensity (NIFI) values were obtained by
selecting a range of wavelengths and calculating the area under the curve of each
fluorescence spectrum. Two separate wavelength ranges were chosen for all calculations
of NIFI. The integration range of 300-410 nm spans the entire fluorescence area while
the integration range of 320-360 nm narrows in on the maximum fluorescence intensity
for each reaction. This was done to account for minor peaks in the fluorescence spectra
and to measure uniformity when comparing results. Two reference NIFIs were used, Lyz
(0.010 mM) for all studies except those with pH or temperature alterations, and Lyz +
PBQ (0.050 mM) (pH=7.0, 37°C) for the studies with pH or temperature alterations. To
quantify the modification of Lysozyme from different studies, a reduced integrated
fluorescence intensity (RIFI) value was calculated by dividing the NIFI of the study in
question by the reference NIFI, converting to a percentage, and then subtracting from
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100%. Reference NIFIs have RIFIs of 0% since 100%-100% = 0% and negative RIFIs
represent an increase in fluorescence intensity since the corresponding NIFI is greater
than the reference NIFI.
Through observation of a reduction of fluorescence intensity and an increase in
absorbance, modification of Lysozyme was confirmed from the results of these studies.

2.3.1

Lysozyme Modifications Induced by PBQ at Various Concentrations
In this study, Lyz (0.010 mM) was treated with PBQ (0.010, 0.050, 0.10, or 0.30

mM) and allowed to react while being monitored using fluorescence for 24 h. Following
the 24 h incubation, dialysis was performed for an additional 24 h followed by a final
spectroscopic measurement of modified Lysozyme. All reactions were performed in a
phosphate buffer (50 mM) at 37°C and pH=7.0 to mimic physiological conditions. To
investigate the influence of using methanol for increasing quinone solubility, one reaction
was performed using a 10% MeOH/90% phosphate buffer when preparing the quinone
solution.
Table 2.1 lists RIFI values calculated over 300-410 nm and 320-360 nm in
addition to absorbance values for each reaction performed in this study. Figure 2.1 shows
the fluorescence intensity of Lysozyme and Lysozyme modified by PBQ (0.010, 0.050,
0.10, or 0.30 mM) for 24 h at 37°C. All spectra were normalized in the 500-550 nm
range where little emission is present to ensure proper comparison. Figure 2.2 shows the
absorbance of Lysozyme and Lysozyme modified by PBQ (0.010, 0.050, 0.10, or 0.30
mM) for 24 h at 37°C.
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Table 2.1

RIFI of Lyz (0.010 mM) and Lyz (0.010 mM) modified by PBQ (0.010,
0.050, 0.10, or 0.30 mM) for 24 h at 37°C. Absorbance at 346 nm of Lyz
(0.010 mM) and Lyz (0.010 mM) modified by PBQ (0.010, 0.050, 0.10, or
0.30 mM) for 24 h at 37°C.
RIFIa (%)

RIFIb (%)

0

0

-0.001

Lyz + PBQ (0.010 mM)

28

29

0.039

Lyz + PBQ (0.050 mM) MeOH

53

53

0.082

Lyz + PBQ (0.050 mM)

57

58

0.094

Lyz + PBQ (0.10 mM) (150526)

65

66

0.125

Lyz + PBQ (0.10 mM) (150713)

66

67

0.123

Lyz + PBQ (0.10 mM) (150513)

70

71

No Data

Lyz + PBQ (0.30 mM)

81

82

0.134

Reaction
Lyz (0.010 mM)

a
b

A346 (a.u.)

integration between 300-410 nm
integration between 320-360 nm

Figure 2.1

Fluorescence spectra of Lyz (0.010 mM) and Lyz (0.010 mM) modified
by PBQ (0.010, 0.050, 0.10, or 0.30 mM) for 24 h at 37°C.
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Figure 2.2

UV-VIS spectra of Lyz (0.010 mM) and Lyz (0.010 mM) modified by
PBQ (0.010, 0.050, 0.10, or 0.30 mM) for 24 h at 37°C.

As seen in Figure 2.1, the fluorescence intensity decreases as the concentration of
PBQ increases in the reaction solution. From the results of previous studies, it was found
exposure of Lysozyme to PBQ elicits protein oligomerization over time. This
oligomerization is believed to cause a decrease in the fluorescence intensity of
Lysozyme. To quantify the degree of modification of Lysozyme, RIFI values were
calculated using Lyz (0.010 mM) as the reference NIFI. As seen in Table 2.1, the RIFI
increases as the concentration of PBQ in the reaction solution increases. This is
interpreted as an increase in the modification of Lysozyme upon exposure to increasing
concentration of PBQ. Considering all reactions performed in this study, Table 2.1
shows no more than a 1% difference in RIFI values calculated over the two integration
ranges.
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As seen in Figure 2.2, the absorbance in the 300-410 nm range increases as the
concentration of PBQ increases in the reaction solution. Since quinone absorbs in this
range, and any free quinone has already been removed through dialysis, the increase in
absorbance is believed to be result of PBQ covalently bonded to Lysozyme. To monitor
this, Table 2.1 shows the absorbance at 346 nm of Lysozyme and modified Lysozyme.
From these results, increasing the concentration of PBQ increases the overall absorbance
of Lysozyme. This is interpreted as an increase in the modification (in this case, adduct
formation) of Lysozyme upon increasing concentration of PBQ.
When considering the effect of using 10% MeOH during quinone preparation,
Table 2.1 shows RIFI values for Lyz + PBQ (0.050 mM) MeOH and Lyz + PBQ (0.050
mM) to be less than 5% of each other. Figures 2.1 and 2.2 support this by showing a
slight difference in the fluorescence and absorbance spectra of the two reactions.
Overall, it can be concluded that the use of 10% MeOH is minimal in affecting the
modification of Lysozyme when exposed to PBQ.
Due to some experimental errors during the reaction PBQ (0.10 mM) (150513),
the UV-VIS spectrum was not recorded. As result, the reaction was duplicated once, then
twice, when differences were observed in the NIFI between the first and second run. The
RIFI for the following two reactions Lyz + PBQ (0.10 mM) (150526) and Lyz + PBQ
(0.10 mM) (150713) were almost identical and varied only by 1%. This confirmed the
difference in NIFI of the first reaction involving Lysozyme incubated with PBQ (0.10
mM) as our method is reliable up to 3% difference in RIFI. As result of the duplications,
it is believed Lysozyme incubated with PBQ (0.10 mM) yields a modification of
Lysozyme by 65-67%.
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In summary, Lysozyme modification was found to be increasing with the
concentration of PBQ. In conjunction with the SDS-PAGE data presented in Chapter 1
[Greve & Kim, 2015], and similar to what was observed during previous studies with
Ribonuclease A, this study shows PBQ exhibits its modifying capabilities through both
induction of protein oligomerization and adduct formation.

2.3.2

Lysozyme Modifications Induced by PBQ Over Various Lengths of Time
In this study, Lyz (0.010 mM) was treated with PBQ (0.050 mM) and allowed to

react while being monitored using fluorescence for 0, 1, 2, 3, and 24 h. Following each
incubation, dialysis was performed for 24 h followed by a final spectroscopic
measurement of modified Lysozyme. All reactions were performed in a phosphate buffer
(50 mM) at 37°C and pH=7.0 to mimic physiological conditions.
Table 2.2 lists RIFI values calculated over 300-410 nm and 320-360 nm in
addition to absorbance values for each reaction performed in this study. Figure 2.3 shows
the fluorescence intensity of Lysozyme and Lysozyme modified by PBQ (0.050 mM) for
0, 1, 2, 3, and 24 h at 37°C. All spectra were normalized in the 500-550 nm range where
little emission is present to ensure proper comparison. Figure 2.4 shows the absorbance
of Lysozyme and Lysozyme modified by PBQ (0.050 mM) for 0, 1, 2, 3, and 24 h at
37°C.
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Table 2.2

RIFI of Lyz (0.010 mM) and Lyz (0.010 mM) modified by PBQ (0.050
mM) for 0 h, 1 h, 2 h, 3 h, and 24 h at pH=7.0 and 37°C. Absorbance at
346 nm of Lyz (0.010 mM) and Lyz (0.010 mM) modified by PBQ (0.050
mM) for 0 h, 1 h, 2 h, 3 h, and 24 h at pH=7.0 and 37°C.
RIFIa (%)

Reaction

A346 (a.u.)

Lyz + PBQ (0.050 mM) 1 h

-17

-18

-0.009

Lyz + PBQ (0.050 mM) 2 h

-13

-15

-0.007

Lyz + PBQ (0.050 mM) 0 h

-13

-13

-0.009

Lyz (0.010 mM) 0 h

-12

-12

0.003

-5

-5

0.007

0

0

-0.001

57

58

0.094

Lyz + PBQ (0.050 mM) 3 h
Lyz (0.010 mM)
Lyz + PBQ (0.050 mM)
a
b

RIFIb (%)

integration between 300-410 nm
integration between 320-360 nm

Figure 2.3

Fluorescence spectra of Lyz (0.010 mM) and Lyz (0.010 mM) modified
by PBQ (0.050 mM) for 0 h, 1 h, 2 h, 3 h, and 24 h at pH=7.0 and 37°C.
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Figure 2.4

UV-VIS spectra of Lyz (0.010 mM) and Lyz (0.010 mM) modified by
PBQ (0.050 mM) for 0 h, 1 h, 2 h, 3 h, and 24 h at pH=7.0 and 37°C.

As seen in Figure 2.3, the fluorescence intensity of Lysozyme and Lysozyme
modified with PBQ increases during the first three hours of incubation. Since each
reaction was performed for a specific amount of time, the results were assumed to vary
according to the incubation time. The resulting increase in fluorescence intensity could
be due to adduct formation or redox cycling of PBQ, both which may increase the
quantum yield of Lysozyme. Since redox cycling results in higher concentrations of the
reduced form of PBQ, the fluorescence intensity would be expected to increase as
reduced PBQ exhibits fluorescence. No protein oligomerization (induced by PBQ) was
assumed to occur during the first three hours as the fluorescence intensity did not
decrease. To quantify the degree of modification of Lysozyme, RIFI values were
calculated using Lyz (0.010 mM) as the reference NIFI. As seen in Table 2.2, the RIFI
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decreases to a maximum during the first hour of incubation and then begins to increase
over time. From the results of this study, one could safely assume the RIFI would
continue increasing for the next several hours until similar results of the reactions Lyz
(0.010 mM) and Lyz + PBQ (0.050 mM) in the previous study were observed.
Considering all reactions performed in this study, Table 2.2 shows no more than a 2%
difference in RIFI values calculated over the two integration ranges.
As seen in Figure 2.4, little to no absorbance occurs in the 300-410 nm range
during the first three hours of incubation. Since quinone absorbs in this range, and any
free quinone has already been removed through dialysis, little adduct formation is
believed to occur during the first three hours of incubation. To monitor this, Table 2.2
shows the absorbance at 346 nm of Lysozyme and modified Lysozyme. From this data,
it is confirmed that three hours of incubation is not enough time to produce lasting
modification of Lysozyme through adduct formation.
When considering the reaction Lyz (0.010 mM) 0 h, Figure 2.3 and Table 2.2
indicate an increase in fluorescence intensity when compared to the reaction Lyz (0.010
mM). This increase could be due to the lack of protein-protein interaction which would
occur over 24 h of incubation. Since the reaction Lyz (0.010 mM) 0 h underwent an
immediate dialysis after Lysozyme was placed in solution, the results indicate the
fluorescence intensity of Lysozyme increases and then decreases over time.
Considering the results of SDS-PAGE studies presented in Chapter 1 [Greve &
Kim, 2015], Lysozyme modification was expected during the first three hours of
incubation with PBQ. From the results of these studies, fluorescence and UV-VIS
spectroscopy did not support previous results regarding the oligomerization of Lysozyme
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during the first three hours of incubation with PBQ although the concentration of
Lysozyme used in SDS-PAGE studies were higher. These results suggest the
fluorescence intensity of Lysozyme is unaffected by PBQ within the first three hours of
incubation but protein oligomerization, initiated by PBQ, still occurs.

2.3.3

Lysozyme Modifications Induced by Substituted Quinones
In this study, Lyz (0.010 mM) was treated with MBQ (0.050 mM), PBQ (0.050

mM), PhBQ (0.050 mM), CBQ (0.050 mM), and TCBQ (0.050 mM) and allowed to react
while being monitored using fluorescence for 24 h. Following the 24 h incubation,
dialysis was performed for an additional 24 h followed by a final spectroscopic
measurement of modified Lysozyme. All reactions were performed in a phosphate buffer
(50 mM) at 37°C and pH=7.0 to mimic physiological conditions.
Table 2.3 lists RIFI values calculated over 300-410 nm and 320-360 nm in
addition to absorbance values for each reaction performed in this study. Figure 2.5 shows
the fluorescence intensity of Lysozyme and Lysozyme modified by MBQ (0.050 mM),
PBQ (0.050 mM), PhBQ (0.050 mM), CBQ (0.050 mM), and TCBQ (0.050 mM) for 24
h at 37°C. All spectra were normalized in the 500-550 nm range where little emission is
present to ensure proper comparison. Figure 2.6 shows the absorbance of Lysozyme and
Lysozyme modified by MBQ (0.050 mM), PBQ (0.050 mM), PhBQ (0.050 mM), CBQ
(0.050 mM), and TCBQ (0.050 mM) for 24 h at 37°C.
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Table 2.3

RIFI of Lyz (0.010 mM) and Lyz (0.010 mM) modified by MBQ (0.050
mM), PBQ (0.050 mM), PhBQ (0.050 mM), CBQ (0.050 mM), and
TCBQ (0.050 mM) for 24 h at 37°C. Absorbance at 346 nm of Lyz (0.010
mM) and Lyz (0.010 mM) modified by MBQ (0.050 mM), PBQ (0.050
mM), PhBQ (0.050 mM), CBQ (0.050 mM), and TCBQ (0.050 mM) for
24 h at 37°C.
RIFIa (%)

RIFIb (%)

0

0

-0.001

Lyz + MBQ (0.050 mM)

36

37

0.019

Lyz + PBQ (0.050 mM)

57

58

0.094

Lyz + PhBQ (0.050 mM)

60

61

0.042

Lyz + CBQ (0.050 mM)

66

67

0.122

Lyz + TCBQ (0.50 mM)

78

79

0.173

Reaction
Lyz (0.010 mM)

a
b

A346 (a.u.)

integration between 300-410 nm
integration between 320-360 nm

Figure 2.5

Fluorescence spectra of Lyz (0.010 mM) and Lyz (0.010 mM) modified
by MBQ (0.050 mM), PBQ (0.050 mM), PhBQ (0.050 mM), CBQ (0.050
mM), and TCBQ (0.050 mM) for 24 h at 37°C.
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Figure 2.6

UV-VIS spectra of Lyz (0.010 mM) and Lyz (0.010 mM) modified by
MBQ (0.050 mM), PBQ (0.050 mM), PhBQ (0.050 mM), CBQ (0.050
mM), and TCBQ (0.050 mM) for 24 h at 37°C.

As seen in Figure 2.5, the fluorescence intensity of Lysozyme decreases upon
exposure to substituted quinones. MBQ was found to cause the smallest decrease in
fluorescence intensity, followed by PBQ, PhBQ, CBQ, and TCBQ. This result is
believed to be linked with the electron donating and electron withdrawing properties of
each substituent. The substituents that are electron donating cause less modification of
Lysozyme than the substituents that are electron withdrawing. MBQ, and to a lesser
extent, PhBQ, have electron donating properties and are found to elicit moderate
modification of Lysozyme. CBQ and TCBQ have electron withdrawing properties and
are found to elicit severe modification of Lysozyme. To quantify the degree of
modification of Lysozyme, RIFI values were calculated using Lyz (0.010 mM) as the
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reference NIFI. As seen in Table 2.3, the RIFI increases as each substituent becomes
more electron withdrawing. This is interpreted as an increase in modification of
Lysozyme by molecules that possess electron withdrawing substituents. Considering all
reactions performed in this study, Table 2.3 shows no more than a 1% difference in RIFI
values calculated over the two integration ranges.
As seen in Figure 2.6, the absorbance in the 300-410 nm range increases in the
same manner as mentioned above. Since quinone absorbs in this range, and any free
quinone has already been removed through dialysis, the increase in absorbance is
believed to be result of substituted quinones covalently bonded to Lysozyme. To monitor
this, Table 2.3 shows the absorbance at 346 nm of Lysozyme and modified Lysozyme.
From these results, as each substituent increases in electron withdrawing capability, the
absorbance increases as well. This is interpreted as an increase in the modification (in
this case, adduct formation) of Lysozyme upon exposure to substituted quinones with
electron withdrawing properties.
Considering the reaction with PhBQ (0.050 mM), Figures 2.5 and 2.6 show
interesting results when examining the order of modification each substituent produces.
Figure 2.5 shows PhBQ to cause a greater decrease in fluorescence intensity than PBQ
while Figure 2.6 shows PhBQ to exhibit less absorbance than PBQ. The results in
previous studies have been found to have correlating results between fluorescence and
UV-VIS spectra. In other words, as the fluorescence intensity decreases, the absorbance
increases. PhBQ shows interesting results because its absorbance is less than what it
supposedly should be. This is particularly interesting due to the structure of PhBQ and its
potential energy absorbing capability.
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In summary, Lysozyme modification was found to be increasing with the electron
withdrawing capability of each substituted quinone. In conjunction with the SDS-PAGE
data presented in Chapter 1 [Greve & Kim, 2015], this study shows substituted quinones
exhibit modifying capabilities through both induction of protein oligomerization and
adduct formation.

2.3.4

Lysozyme Modifications Induced by Naphthoquinones
In this study, Lyz (0.010 mM) was treated with HNQ (0.050 mM), PNQ (0.050

mM), and ONQ (0.050 mM) and allowed to react while being monitored using
fluorescence for 24 h. Following the 24 h incubation, dialysis was performed for an
additional 24 h followed by a final spectroscopic measurement of the modified
Lysozyme. All reactions were performed in a phosphate buffer (50 mM) at 37°C and
pH=7.0 to mimic physiological conditions.
Table 2.4 lists RIFI values calculated over 300-410 nm and 320-360 nm in
addition to absorbance values for each reaction performed in this study. Figure 2.7 shows
the fluorescence intensity of Lysozyme and Lysozyme modified by HNQ (0.050 mM),
PNQ (0.050 mM), and ONQ (0.050 mM) for 24 h at 37°C. All spectra were normalized
in the 500-550 nm range where little emission is present to ensure proper comparison.
Figure 2.8 shows the absorbance of Lysozyme and Lysozyme modified by HNQ (0.050
mM), PNQ (0.050 mM), and ONQ (0.050 mM) for 24 h at 37°C.

49

Table 2.4

RIFI of Lyz (0.010 mM) and Lyz (0.010 mM) modified by HNQ (0.050
mM), PNQ (0.050 mM), and ONQ (0.050 mM) for 24 h at 37°C.
Absorbance at 346 nm of Lyz (0.010 mM) and Lyz (0.010 mM) modified
by HNQ (0.050 mM), PNQ (0.050 mM), and ONQ (0.050 mM) for 24 h at
37°C.
RIFIa (%)

RIFIb (%)

0

0

-0.001

Lyz + HNQ (0.050 mM)

29

29

0.025

Lyz + PNQ (0.050 mM)

43

43

0.014

Lyz + ONQ (0.050 mM)

60

61

0.081

Reaction
Lyz (0.010 mM)

a
b

A346 (a.u.)

integration between 300-410 nm
integration between 320-360 nm

Figure 2.7

Fluorescence spectra of Lyz (0.010 mM) and Lyz (0.010 mM) modified
by HNQ (0.050 mM), PNQ (0.050 mM), and ONQ (0.050 mM) for 24 h at
37°C.
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Figure 2.8

UV-VIS spectra of Lyz (0.010 mM) and Lyz (0.010 mM) modified by
HNQ (0.050 mM), PNQ (0.050 mM), and ONQ (0.050 mM) for 24 h at
37°C.

As seen in Figure 2.7, the fluorescence intensity of Lysozyme decreases upon
exposure to naphthoquinones. From the results of previous SDS-PAGE studies
mentioned in Chapter 1, naphthoquinones have been found to produce little, if not any,
protein modifying behavior [Smith & Kim, 2015]. In this study, HNQ, PNQ, and ONQ
were all found to produce modification of Lysozyme. To quantify the degree of
modification of Lysozyme, RIFI values were calculated using Lyz (0.010 mM) as the
reference NIFI. As seen in Table 2.4, ONQ produced the largest RIFI followed by PNQ
and HNQ, respectively. This is interpreted as HNQ causing the least modification of
Lysozyme and ONQ causing the greatest modification of Lysozyme. Considering all
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reactions performed in this study, Table 2.4 shows no more than a 1% difference in RIFI
values calculated over the two integration ranges.
As seen in Figure 2.8, the absorbance in the 300-410 nm range increases as usual
for quinone-incubated solutions with an additional increase in the 400-500 nm range due
to the color of solution. Since naphthoquinone absorbs in this range, and any free
naphthoquinone has already been removed through dialysis, the increase in absorbance is
believed to be result of naphthoquinone covalently bonded to Lysozyme. To monitor
this, Table 2.4 shows the absorbance at 346 nm of Lysozyme and modified Lysozyme.
From these results, ONQ shows the largest absorbance, followed by HNQ then PNQ,
respectively. This is interpreted as ONQ causing the largest degree of Lysozyme
modification and HNQ and PNQ exhibiting a similar phenomenon as seen in the study
with quinone substituents.
Considering the structure of each naphthoquinone used in this study, the results of
this study demonstrate how the position of the double bonded oxygen on the
naphthoquinone plays a role in its protein modifying capability. Figures 2.7 and 2.8
show ONQ to elicit the greatest modification of Lysozyme and PNQ and HNQ to elicit
varying degrees of modification of Lysozyme. Since the UV-VIS absorbance of PNQ in
the 300-410 nm range is relatively absent, it can be assumed PNQ does not exhibit its
protein modifying behavior through adduct formation but rather by induction of protein
oligomerization. In contrast, since the UV-VIS absorbance of HNQ in the 300-410 nm
range is prominent, and the RIFI of HNQ is less than PNQ, it can be assumed HNQ
exhibits its protein modifying behavior through adduct formation rather than induction of
protein oligomerization. Going further, the double bonded oxygen at the ortho- position
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seems to elicit the largest degree of Lysozyme modification. Comparing HNQ with
PNQ, it appears the hydroxyl group on HNQ favors adduct formation while the double
bonded oxygen at the para- position acts much like PBQ regarding induction of protein
oligomerization.
In summary, Lysozyme modification, regardless of degree, was found with all
naphthoquinones used in this study. Consistent with SDS-PAGE data presented in
Chapter 1 [Smith & Kim, 2015], this study suggests naphthoquinones, specifically ONQ,
HNQ, and PNQ, exhibit modifying capabilities towards Lysozyme through both
induction of protein oligomerization and adduct formation.

2.3.5

Lysozyme Modifications Induced by PBQ at Various pH
In this study, Lyz (0.010 mM) was treated with PBQ (0.050 mM) and allowed to

react at pH=6.0, pH=7.0, and pH=8.0 while being monitored using fluorescence for 24 h.
Following the 24 h incubation, dialysis was performed for an additional 24 h followed by
a final spectroscopic measurement of modified Lysozyme. All reactions were performed
in a phosphate buffer (50 mM) at 37°C.
Table 2.5 lists RIFI values calculated over 300-410 nm and 320-360 nm in
addition to absorbance values for each reaction performed in this study. Figure 2.9 shows
the fluorescence intensity of Lysozyme and Lysozyme modified by PBQ (0.050 mM) at
pH=6.0, pH=7.0, and pH=8.0 for 24 h at 37°C. All spectra were normalized in the 500550 nm range where little emission is present to ensure proper comparison. Figure 2.10
shows the absorbance of Lysozyme and Lysozyme modified by PBQ (0.050 mM) at
pH=6.0, pH=7.0, and pH=8.0 for 24 h at 37°C.
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Table 2.5

RIFI of Lyz (0.010 mM) and Lyz (0.010 mM) modified by HNQ (0.050
mM), PNQ (0.050 mM), and ONQ (0.050 mM) for 24 h at 37°C.
Absorbance at 346 nm of Lyz (0.010 mM) and Lyz (0.010 mM) modified
by HNQ (0.050 mM), PNQ (0.050 mM), and ONQ (0.050 mM) for 24 h at
37°C.
RIFIa (%)

Reaction

RIFIb (%)

A346 (a.u.)

Lyz + PBQ (0.050 mM) pH=6.0

-20

-21

0.049

Lyz + PBQ (0.050 mM) pH=7.0

0

0

0.094

Lyz + PBQ (0.050 mM) pH=8.0

47

48

0.171

a
b

integration between 300-410 nm
integration between 320-360 nm
150,000

Fluorescence Intensity (a.u.)

125,000
Lyz + PBQ (0.050 mM) pH=6.0

100,000
Lyz + PBQ (0.050 mM) pH=7.0

75,000
Lyz + PBQ (0.050 mM) pH=8.0

50,000

25,000

0
280

310

340

370

400

430

460

490

520

550

Wavelength (nm)
Figure 2.9

Fluorescence spectra of Lyz (0.010 mM) modified by PBQ (0.050 mM) at
pH=6.0, pH=7.0, and pH=8.0 for 24 h at 37°C.
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Figure 2.10

UV-VIS spectra of Lyz (0.010 mM) modified by PBQ (0.050 mM) at
pH=6.0, pH=7.0, and pH=8.0 for 24 h at 37°C.

As seen in Figure 2.9, the fluorescence intensity decreases as the pH of the
reaction solution increases. This is believed to be due to increasing the nucleophilic
character of the protein as the pH increases and therefore increasing the association of
Lysozyme and PBQ. To quantify this degree of modification of Lysozyme, RIFI values
were calculated using Lyz + PBQ (0.050 mM) pH=7.0 as the reference NIFI. As seen in
Table 2.5, the RIFI increases as the pH increases and decreases as the pH decreases. This
is interpreted as an increase of modification of Lysozyme when increasing the pH and a
decrease of modification of Lysozyme when decreasing the pH. Obviously, incubating
Lysozyme with PBQ regardless of the pH causes a modification of Lysozyme. However,
considering conditions at physiological pH, a decrease in pH causes less modification of
Lysozyme and an increase in pH causes a greater modification of Lysozyme.
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Considering all reactions performed in this study, Table 2.5 shows no more than a 1%
difference in RIFI values calculated over the two integration ranges.
As seen in Figure 2.10, the absorbance in the 300-410 nm range increases as the
pH of the reaction solution increases. Since quinone absorbs in this range, and any free
quinone has already been removed through dialysis, the increase and decrease in
absorbance is believed to be result of PBQ covalently bonded to Lysozyme. To monitor
this, Table 2.5 shows the absorbance at 346 nm of Lysozyme incubated with PBQ at
pH=6.0, pH=7.0, and pH=8.0. From these results, increasing the pH of the reaction
solution increases the absorbance. Again, any incubation of Lysozyme with PBQ will
cause an increase in the overall absorbance of Lysozyme, however, in this study,
comparisons to physiological pH were made, and increases and decreases in absorbance
were noted as result.
Considering the results of this study, several assumptions can be made. For
example, increasing the pH of solution gives rise to increasing deprotonation of
Lysozyme which results in greater attractive forces between PBQ and Lysozyme. In
addition, decreasing the pH of solution gives rise to increasing protonation of Lysozyme
and PBQ which results in greater repulsive forces between PBQ and Lysozyme.
In summary, Lysozyme modification was found to be dependent on varying the
pH of the reaction. This study suggests PBQ exhibits its modifying capabilities through
both induction of protein oligomerization and adduct formation at multiple pH values.
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2.3.6

Lysozyme Modifications Induced by PBQ at Various Temperatures
In this study, Lyz (0.010 mM) was treated with PBQ (0.050 mM) and allowed to

react at 27°C, 37°C, and 42°C while being monitored using fluorescence for 24 h.
Following the 24 h incubation, dialysis was performed for an additional 24 h followed by
a final spectroscopic measurement of modified Lysozyme. All reactions were performed
in a phosphate buffer (50 mM) at pH=7.0.
Table 2.6 lists RIFI values calculated over 300-410 nm and 320-360 nm in
addition to absorbance values for each reaction performed in this study. Figure 2.11
shows the fluorescence intensity of Lysozyme and Lysozyme modified by PBQ (0.050
mM) at 27°C, 37°C, and 42°C for 24 h at pH=7.0. All spectra were normalized in the
500-550 nm range where little emission is present to ensure proper comparison. Figure
2.12 shows the absorbance of Lysozyme and Lysozyme modified by PBQ (0.050 mM) at
27°C, 37°C, and 42°C for 24 h at pH=7.0.
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Table 2.6

RIFI of Lyz (0.010 mM) modified by PBQ (0.050 mM) at 27°C, 37°C,
and 42°C for 24 h at pH=7.0. Absorbance at 346 nm of Lyz (0.010 mM)
modified by PBQ (0.050 mM) at 27°C, 37°C, and 42°C for 24 h at
pH=7.0.
RIFIa (%)

Reaction

RIFIb (%)

A346 (a.u.)

Lyz + PBQ (0.050 mM) 27°C

-32

-34

0.057

Lyz + PBQ (0.050 mM) 37°C

0

0

0.094

Lyz + PBQ (0.050 mM) 42°C

21

22

0.119

a
b

integration between 300-410 nm
integration between 320-360 nm
175,000

Fluorescence Intensity (a.u.)

150,000

125,000

Lyz + PBQ (0.050 mM) 27°C

100,000

Lyz + PBQ (0.050 mM) 37°C

75,000

Lyz + PBQ (0.050 mM) 42°C
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25,000

0
280
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Figure 2.11

Fluorescence spectra of Lyz (0.010 mM) modified by PBQ (0.050 mM) at
27°C, 37°C, and 42°C for 24 h at pH=7.0.
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Figure 2.12

UV-VIS spectra of Lyz (0.010 mM) modified by PBQ (0.050 mM) at
27°C, 37°C, and 42°C for 24 h at pH=7.0.

As seen in Figure 2.11, the fluorescence intensity decreases as the temperature of
the reaction solution increases. This is believed to be due to speeding up the kinetics of
the reaction and possibly altering the shape and size of Lysozyme by changing the
temperature. When Lysozyme and PBQ in solution are moving around at a greater speed
due to an increase in the temperature of the reaction solution, a greater possibility of
association can occur. Conversely, when Lysozyme and PBQ in solution are moving
around at a reduced speed due to a decrease in the temperature of the reaction solution, a
reduced possibility of association can occur. To quantify this degree of modification of
Lysozyme, RIFI values were calculated using Lyz + PBQ (0.050 mM) 37°C as the
reference NIFI. As seen in Table 2.6, the RIFI increases as the temperature increases and
decreases as the temperature decreases. This is interpreted as an increase of modification
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of Lysozyme when increasing the temperature and a decrease of modification of
Lysozyme when decreasing the temperature. Similar to the previous study, incubating
Lysozyme with PBQ regardless of the temperature of the reaction solution causes a
modification of Lysozyme. However, considering conditions at physiological
temperature (37°C), a decrease in temperature causes less modification of Lysozyme and
an increase in temperature causes a greater modification of Lysozyme. Considering all
reactions performed in this study, Table 2.6 shows no more than a 2% difference in RIFI
values calculated over the two integration ranges.
As seen in Figure 2.12, the absorbance in the 300-410 nm range increases as the
temperature of the reaction solution increases. Since quinone absorbs in this range, and
any free quinone has already been removed through dialysis, the increase in absorbance is
believed to be result of PBQ covalently bonded to Lysozyme. To monitor this, Table 2.6
shows the absorbance at 346 nm of Lysozyme incubated with PBQ at 27°C, 37°C, and
42°C. From these results, increasing the temperature of the reaction solution increases
the absorbance at 346 nm. Again, any incubation of Lysozyme with PBQ will cause an
increase in the overall absorbance of Lysozyme due to covalently bonded PBQ
molecules, however, in this study, comparisons to physiological temperature were made,
and increases in absorbance were noted as temperature increases.
In summary, Lysozyme modification was found to be increasing with respect to
increasing temperature. This study shows again that PBQ exhibits its modifying
capabilities through both induction of protein oligomerization and adduct formation at
multiple temperatures.
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2.4 Conclusions

Lysozyme modifications were observed with all quinone incubations as well as
when environmental conditions were altered for reactions involving Lysozyme and PBQ.
Six different studies were performed and each study provided insight on the modification
of Lysozyme. Lysozyme modification, through protein oligomerization and adduct
formation, was found to be increasing with the concentration of PBQ. Specifically,
Lysozyme modification appears to be dominated by redox cycling and adduct formation
within the first 3 h of incubation with PBQ. As the electron withdrawing capability of
substituents on PBQ increases, so does modification of Lysozyme through protein
oligomerization and adduct formation. Naphthoquinones elicit similar modification to
Lysozyme with ONQ producing the largest modification. Considering environmental
conditions, Lysozyme modification was found to be dependent on varying both the pH
and temperature of the reaction solution.
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CHAPTER 3
STUDIES OF RIBONUCLEASE A MODIFICATIONS
INDUCED BY 2-HYDROXY-1,4-NAPHTHOQUINONE
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3.1 Introduction

In previous SDS-PAGE studies performed by Smith & Kim, HNQ was not found
to produce protein crosslinking of Ribonuclease A [Smith & Kim, 2015]. Instead, HNQ
was assumed to elicit adduct formation which was too sensitive of a modification to be
detected by SDS-PAGE. In the study here, fluorescence and UV-VIS spectroscopy were
used to aid previous research by investigating the modification of Ribonuclease A by
HNQ.

3.2 Methodology

All chemicals were purchased from Acros Organics and were of reagent grade.
The protein of interest, Ribonuclease A (from bovine pancreas), was purchased from
Fisher and kept frozen for preservation until ready for use. All water used in this study
was deionized (DI) water purified by a Millipore system (Milli-Q). All solutions were
made in lab and kept sealed or covered until ready for use. All reactions were performed
in a similar manner following the devised experimental protocol to keep error at a
minimum. Each study was performed over a three-day period consisting of (1)
preparing and starting the reaction, (2) performing dialysis of the incubated solution, and
(3) finishing the reaction. Quartz cuvettes, purchased from Starna Cells, Inc., were reused after being thoroughly cleaned with Starna Cells, Inc. cuvette cleaner and allowed
to dry. Physiological conditions (pH=7.0, 37°C) were modeled for all reactions except
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for the studies in which the pH was varied. At all times, proper laboratory protocol was
followed and the laboratory was kept in clean and functional condition.

3.2.1

Buffer Solution
A phosphate buffer (50 mM), comprised of a mixture of monobasic monosodium

phosphate crystal (NaH2PO4·H2O) and dibasic disodium phosphate anhydrous
(Na2HPO4), was prepared and used for all reactions in this study. Most reactions were
performed at pH=7.0 and 37°C to mimic physiological conditions; however, additional
reactions were performed at a different pH to study the effect of changing the
environmental factors. The phosphate buffer solution was used in every 3 mL reaction
cuvette as well as in 1 L beakers when performing dialysis. Solutions of NaH2PO4·H2O
(50 mM) and Na2HPO4 (50mM) were combined in ratios to produce a solution at a pH
pre-determined by the Henderson-Hasselbalch equation (Eq. 3.1).
[𝑏𝑎𝑠𝑒]

𝑝𝐻 = 𝑝𝐾𝑎 + 𝑙𝑜𝑔 [𝑎𝑐𝑖𝑑]

(Eq. 3.1)

A phosphate buffer solution was chosen primarily because of the multiple
dissociation constants of phosphoric acid. Since the second deprotonation of phosphoric
acid has a pKa around 7.2, an equilibrium between NaH2PO4·H2O and Na2HPO4 creates
an effective buffering range around pH=7.0. Due to the physiological approach of the
study, the use of phosphates in the buffer solution keeps the study in line with biological
systems.
To perform a reaction, 4 L of buffer was made fresh the day before each reaction.
14.19 g of Na2HPO4 (50mM) was weighed and carefully poured in a 2 L volumetric flask
followed by dilution to the line with deionized water. Following the same procedure,
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13.79 g of NaH2PO4·H2O (50 mM) was weighed and carefully poured in a similar 2 L
volumetric flask, again diluting to the line with deionized water. To have enough
Na2HPO4 (50 mM) for pH=7.0, an additional 0.0500 L of Na2HPO4 (50 mM) was made
by weighing 3.55 g of Na2HPO4 (50 mM) and following the same dilution and mixing
protocol mentioned above. These flasks were subjected to stirring by mechanical means
for roughly 30 min. Once fully dissolved, the two solutions of acid and base were
combined in pre-determined ratios, 1 L at a time, to produce the desired pH of the buffer.
For example, for a buffer solution at pH=7.0, 557 mL of Na2HPO4 (50 mM) was
combined with 443 mL of NaH2PO4·H2O (50 mM), adequately mixed, and transferred
into a 4 L plastic jug. This process was repeated three additional times to produce 4 L of
buffer solution. The final pH of solution was checked using a Fisher AB15 Accumet pH
meter equipped with an AccuTupH probe. After calibration with stock solutions at
pH=4.00 and pH=10.01, if the pH of the buffer solution was within ± 0.05 units of the
desired pH, the solution was acceptable and was stored in the fridge at 4°C until ready for
use.

3.2.2

Protein Solution
Ribonuclease A stock solutions were made to provide enough protein for the

extent of this study. This involved carefully weighing an imprecise amount of
Ribonuclease A, 0.1221 g, onto tared weigh-paper and quantitatively transferring into a
10 mL volumetric flask. Phosphate buffer (50 mM, pH=7.0) was used to wash any
residual Ribonuclease A off the weigh-paper into the volumetric flask. Ribonuclease A,
in the volumetric flask, was diluted to the line with phosphate buffer (50 mM, pH=7.0)
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and the flask was capped and sealed with ParaFilm. To facilitate the protein into
solution, sonication was performed for 15 min in addition to inversion and shaking the
volumetric flask by hand. After sonication, the protein solution was carefully transferred
to Eppendorf tubes and stored in the freezer until needed.
The concentration of stock Ribonuclease A was calculated by converting 0.1221 g
of Ribonuclease A to moles of Ribonuclease A and then dividing by 0.0100 L. To
convert grams to moles, 0.1221 g of Ribonuclease A was divided by 13682 g/mol, the
molecular weight of Ribonuclease A. This value was then divided by 0.0100 L to
determine the molarity, or concentration, of the stock Ribonuclease A. Finally, this
concentration was multiplied by 1000 to express the concentration in mM, a unit easier to
manipulate during future calculations. As result, the concentration of stock Ribonuclease
A was determined to be 0.8924 mM.
To perform a reaction, one Eppendorf tube containing the stock Ribonuclease A
was retrieved from the freezer and allowed to thaw out on ice for 20 min, on the counter
for 20 min, and finally in the hand for a few minutes. Once completely thawed, the
protein solution was vortexed for 1 min to ensure homogeneity before being ready for
use.
For all studies involving the modification of Ribonuclease A by HNQ,
Ribonuclease A was fixed at a concentration of 0.050 mM. Calculations were performed
to determine the exact volume of stock Ribonuclease A to add to each reaction cuvette to
obtain a Ribonuclease A concentration of 0.050 mM. This was performed using
Equation 3.2 where M1 is the concentration of stock Ribonuclease A (0.8924 mM), V1 is
the required aliquot of stock Ribonuclease A to be added to the reaction cuvette, M2 is the
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desired concentration of RNase A (0.050 mM), and V2 is the desired volume in the
reaction cuvette (3000 μL).
𝑀1 𝑉1 = 𝑀2 𝑉2

(Eq. 3.2)

As result, 168 μL of stock Ribonuclease A was transferred to a 3 mL reaction
cuvette containing phosphate buffer (50 mM) to achieve a Ribonuclease A concentration
of 0.050 mM used for all studies.

3.2.3

Quinone Solution
Solutions of HNQ were made fresh for every reaction performed. This involved

weighing an amount of HNQ on tared weigh-paper (a mass between 0.0100 g and 0.0200
g) and quantitatively transferring to a 10 mL volumetric flask. To ensure all protein was
transferred into the volumetric flask, 10% MeOH/90% phosphate buffer (50 mM) was
used to wash any residual HNQ off the weigh-paper into the volumetric flask. HNQ, in
the volumetric flask, was diluted to the line with 10% MeOH/90% phosphate buffer (50
mM) and capped and sealed with ParaFilm. To facilitate HNQ into solution, sonication
was performed for 10 min in addition to inversion and shaking the volumetric flask by
hand. Halfway through the sonication procedure, the volumetric flask was removed,
inverted to mix the solution, and then placed back into the sonicator. After sonication,
the HNQ solution was transferred into a small holding beaker, covered with foil, and was
ready for use.
It is important to note that only the volumetric flask containing the HNQ solution
contained 10% MeOH. Once the HNQ, in solution, was transferred from the small
holding beaker to the reaction cuvette, phosphate buffer (50 mM) was used to bring the
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reaction cuvette up to volume. Over all studies performed, the relative concentration of
10% MeOH in the reaction cuvette was minimal and not enough to influence the reaction
being performed.
During the sonication procedure, the concentration of HNQ prepared in solution
was calculated by converting the mass of HNQ to moles of HNQ and then dividing by
0.0100 L. To convert grams of HNQ to moles of HNQ, the mass of HNQ was divided by
the molar mass of HNQ. This value was then divided by 0.0100 L to determine the
molarity, or concentration, of the quinone in solution. Finally, this concentration was
multiplied by 1000 to express the concentration in mM, a unit easier to manipulate during
future calculations.
In addition, further calculations were performed during the sonication process to
determine the exact volume of HNQ solution to add to the reaction cuvette containing
RNase A (0.050 mM) and phosphate buffer (50 mM) to achieve the desired concentration
of HNQ in the reaction cuvette. This was calculated using Equation 3.3 where, in this
case, M1 is the actual concentration of the HNQ solution prepared, V1 is the required
aliquot of HNQ solution to be added to the reaction cuvette, M2 is the desired
concentration of HNQ, and V2 is the desired volume in the reaction cuvette (3000 μL).
𝑀1 𝑉1 = 𝑀2 𝑉2

(Eq. 3.3)

Since several concentrations of HNQ were used across all studies, and the amount
of HNQ weighed out each time was not the same, the amount of HNQ solution added to
the reaction cuvette varied reaction to reaction.
For the study involving different concentrations of HNQ, aliquot volumes were
calculated for desired concentrations of 0.050 mM, 0.10 mM, 0.25 mM, 0.50 mM, and
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1.5 mM. For the study involving HNQ incubated with Ribonuclease A at different pH,
aliquot volumes were calculated for a fixed concentration of 0.10 mM. This
concentration was determined best to work with when comparing different variables of
reactions because it provided a concentration high enough to interact well with
Ribonuclease A.
Once the calculated volume of HNQ solution was added to the reaction cuvette
containing RNase A (0.050 mM) and phosphate buffer (50 mM), the reaction began, the
cuvette was placed into the fluorimeter for scanning, and the reaction time was kept on a
scientific timer.

3.2.4

Fluorescence Spectroscopy & Anisotropy Measurements
Fluorescence spectroscopy was performed using a Horiba Jobin Yvon Fluorolog

spectrophotometer equipped with a Xenon lamp. The excitation wavelength was fixed at
280 nm with a 2 nm slit width to accommodate the tyrosine residues in Ribonuclease A.
The resulting emission was recorded every 1 nm with a slit width of 2 nm over the range
of 290-600 nm. To draw correlations between all studies, each spectrum was normalized
from 500-550 nm where little emission was recorded. Microsoft Excel was used to
analyze the data and to produce graphs to visualize the fluorescence spectra.
All reactions were performed in a quartz cuvette in phosphate buffer (50 mM).
The cuvette was equipped with a stir bar to ensure proper mixing and to minimize
sedimentation of Ribonuclease A. The stirring motion was set to the 3rd level of power as
indicated on the fluorimeter. Emission scanning lasted around 10 min and varied
occasionally in duration due to mechanical motion inside of the fluorimeter. Initial
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scanning, or reaction scanning, of Ribonuclease A occurred over 24 h with scans
occurring every hour for that duration. Post-modified Ribonuclease A was returned to a
quartz cuvette after a 24 h dialysis and scanned an additional four times. This resulting
data was recorded, averaged, and analyzed in Microsoft Excel to produce the graphs
presented in this study. A control was produced by subjecting RNase A (0.050 mM) in
phosphate buffer (50 mM) to the same procedure as every reaction performed.
The software to operate the fluorimeter was FluorEssence by Horiba Jobin Yvon.
This software was capable of automating fluorescence and anisotropy scans which were
utilized to accomplish the 24 h scans of each study. The first and second scans were
always started manually with each consecutive scan being automatically started by the
programming. Since each emission scan lasted around 10 min (600 s), the instrument
was programmed to scan the reaction every 2997 s for 24 h to accomplish 24 h of
scanning each hour. Due to the mechanical motion of parts inside of the fluorimeter, an
additional 3 s was added to accommodate the automated re-calibration of the instrument
after each scan. Due to fluctuations in voltage supplied to the instrument, the timing of
the scans slightly varied for each reaction and occasionally needed to be reset during the
reaction.
The process of performing fluorescence measurements was performed in a similar
manner for every reaction by following a pre-determined protocol. To begin, the
fluorimeter was turned on by first switching on the water bath, the fan, the lamp, and then
the software PC. The lamp was allowed to warm up for 1 h before any measurements
took place. The instrument was initialized by selecting to perform a spectra study,
specifically an emission study, and then by executing a trial scan (C1-Trial) with the

70

cuvette containing only Ribonuclease A and phosphate buffer (50 mM). Once the
initialization was complete and the trial scan was acceptable, the software was used to
program the instrument for fluorescence measurements. A scientific timer was obtained
and started as soon as the aliquot of HNQ was administered to the reaction cuvette
containing Ribonuclease A and phosphate buffer. After this, the reaction cuvette was
capped, the sides wiped with Kimwipes, inverted 3 times, and placed in the fluorimeter
for scanning. Once securely positioned inside the fluorimeter, the fluorescence scanning
was started and the time on the scientific timer was recorded. This time was the delay
between the actual start of the reaction of Ribonuclease A with HNQ and the initial
emission scanning of the reaction. In addition, the time of day was recorded to be able to
monitor the start and stop of each consecutive measurement every hour.
Post-modified Ribonuclease A fluorescence measurements were performed using
a different programmed scanning procedure as initial scanning. In these scans, modified
Ribonuclease A was scanned four times in the time frame of 1 h at 37°C. Once these
scans were complete, the cuvette was removed from the fluorimeter and the instrument
was shut down in the reverse order in was turned on. This concluded the use of
fluorescence spectroscopy to measure the modification of Ribonuclease A induced by
HNQ.
In addition to fluorescence measurements, anisotropy measurements were
performed as well during initial and post-modified scanning of Ribonuclease A.
Appendix B shows anisotropy measurements for each study performed using
Ribonuclease A. A general trend can be seen in each graph indicating the correlation
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between increasing modification of Ribonuclease A and increasing anisotropy values of
Ribonuclease A.
Overall, the studies performed with fluorescence spectroscopy helped aid
previous research in positively confirming modification of Ribonuclease A by HNQ.

3.2.5

UV-VIS Spectroscopy
UV-VIS spectroscopy was performed using a double-beam UV-1800 Shimadzu

UV Spectrophotometer. The instrument was allowed to warm up for 20 min before any
measurements took place. Excitation was achieved using a D2/W lamp with the resulting
spectra recorded at 1 nm sampling intervals over the range of 200-700 nm with the scan
speed set to fast. The slit width was 1.0 nm and the D2/W light change was set at 340.8
nm. The instrument was auto-zeroed and baselined prior to every scan to account for
background noise. Microsoft Excel was used to analyze the data recorded and to produce
the graphs presented in this study.
Immediately after fluorescence scanning was complete, the cuvette was
transferred into the UV-VIS spectrophotometer for analysis. Absorbance of the analyte
was recorded and immediately processed on screen using the software UV Probe 2.33. A
reference cell containing phosphate buffer (50 mM, pH=7.0) was prepared at the
beginning of the study and was used for every reaction throughout the study. This
insured the absorbance calculated by the instrument was solely from Ribonuclease A and
any bound or unbound HNQ. Pre-dialysis Ribonuclease A exhibited larger absorbance
than post-dialysis Ribonuclease A due to unbound HNQ in solution absorbing light.
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Removal of unbound HNQ by dialysis reduced the absorbance of the analyte and
produced a more accurate representation of modified Ribonuclease A.
All UV-VIS measurements were performed in the same manner and used to
measure the amount of modification (by adduct formation) of Ribonuclease A. Overall,
the studies performed with UV-VIS spectroscopy helped aid previous research in
positively confirming modification of Ribonuclease A by HNQ.

3.2.6

Dialysis
To accurately measure the modification of Ribonuclease A induced by HNQ,

dialysis was performed to remove unbound HNQ that was not covalently bonded to
Ribonuclease A. Spectroscopically measuring Ribonuclease A with bound HNQ alone
gives clear understanding of the modification of Ribonuclease A induced by HNQ.
Dialysis was performed using a 5 mL Float-A-Lyzer purchased from Spectrum
Laboratories. The membrane, with a molecular cutoff of 3.5 kDa, allowed unbound
HNQ to freely exit through the membrane. Ribonuclease A, with a molecular mass of
13.6 kDa, or modified Ribonuclease A, with a slightly higher molecular mass, remained
inside of the dialysis membrane along with any HNQ bound to the protein via ionic
bonding, covalent bonding, or H-bonding. Before use, each dialysis membrane was
thoroughly soaked, washed, and rinsed with DI water and then temporarily held in
phosphate buffer solution (50 mM) kept at 4°C. Before the reaction solution could be
transferred into the dialysis membrane, the membrane was emptied of phosphate buffer
solution to insure proper concentration of the protein and HNQ in solution. Once the
reaction solution was carefully transferred from the reaction cuvette to the dialysis
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membrane by a disposable pipette, the dialysis membrane was placed in 900 mL of
phosphate buffer solution and kept at 4°C for 24 h. Facilitation of unbound HNQ out of
the dialysis membrane was accelerated by the concentration gradient between the
phosphate buffer solution and the reaction solution as well as by stirring using a stir bar.
Since the concentration of quinone outside of the dialysis membrane was less than the
concentration of quinone inside of the dialysis membrane, simple diffusion occurred and
the unbound HNQ exited the dialysis membrane. This was further accelerated by
changing out the phosphate buffer solution three times, typically every 2.5 h. By doing
this, the concentration gradient became smaller each time and diffusion continued to take
place. After three buffer changes, and considering the volume of reaction solution to
phosphate buffer solution, it is safe to assume all unbound HNQ had been washed from
the reaction solution.
After 24 h of dialysis, the contents in the dialysis membrane were returned to a
clean reaction cuvette and placed in the fluorimeter for post-dialysis fluorescence
scanning. By removal of unbound quinone in solution, the modification of Ribonuclease
A by bound HNQ was measured and quantified by fluorescence and UV-VIS
spectroscopy.

3.3 Results and Discussion

The results of several reactions involving Ribonuclease A are presented below. Two
official studies were conducted: (1) a study with HNQ at various concentrations, and (2)
a study focused on the pH dependence of HNQ. Fluorescence and UV-VIS graphs are
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included for each study. The graphs depict the fluorescence intensity and absorbance of
post-dialysis Ribonuclease A. Post-dialysis Ribonuclease A (i.e. modified Ribonuclease
A) refers to Ribonuclease A which has completed a 24 h dialysis and contains only
Ribonuclease A and any bound quinone to the protein.
Normalized integrated fluorescence intensity (NIFI) values were obtained by
selecting a range of wavelengths and calculating the area under the curve of each
fluorescence spectrum. Two separate wavelength ranges were chosen for all calculations
of NIFI. The integration range of 290-400 nm spans the entire emission area while the
integration range 300-330 nm narrows in on the maximum fluorescence intensity for each
reaction. This was done to account for minor blips in the fluorescence spectra and to
measure uniformity when comparing results. Two reference NIFIs were used, RNase A
(0.050 mM) for the study with HNQ at various concentrations and RNase A + HNQ (0.10
mM) pH=7.0 for the study focused on the pH dependence of HNQ. To quantify the
modification of Ribonuclease A from different studies, a reduced integrated fluorescence
intensity (RIFI) value was calculated by dividing the NIFI of the study in question by the
reference NIFI, converting to a percentage, and then subtracting from 100%. Reference
NIFIs have RIFIs of 0% since 100%-100% = 0% and negative RIFIs represent an
increase in fluorescence intensity since the corresponding NIFI is greater than the
reference NIFI.
Through observation of a reduction of fluorescence intensity and an increase in
absorbance, modification of Ribonuclease A was confirmed from the results of these
studies.
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3.3.1

Ribonuclease A Modifications Induced by HNQ at Various Concentrations
In this study, RNase A (0.050 mM) was treated with HNQ (0.050, 0.10, 0.25,

0.50, or 1.5 mM) and allowed to react while being monitored using fluorescence for 24 h.
Following the 24 h incubation, dialysis was performed for an additional 24 h followed by
a final spectroscopic measurement of modified Ribonuclease A. All reactions were
performed in a phosphate buffer (50 mM) at 37°C and pH=7.0 to mimic physiological
conditions.
Table 3.1 lists RIFI values calculated over 290-400 nm and 300-330 nm in
addition to absorbance values for each reaction performed in this study. Figure 3.1 shows
the fluorescence intensity of Ribonuclease A and Ribonuclease A modified by HNQ
(0.050, 0.10, 0.25, 0.50, or 1.5 mM) for 24 h at 37°C. All spectra were normalized in the
500-550 nm range where little emission is present to ensure proper comparison. Figure
3.2 shows the absorbance of Ribonuclease A and Ribonuclease A modified by HNQ
(0.050, 0.10, 0.25, 0.50, or 1.5 mM) for 24 h at 37°C.
As seen in Figure 3.1, the fluorescence intensity decreases as the concentration of
HNQ increases in the reaction solution. From the results of previous studies, it was
found exposure of Ribonuclease A to HNQ does not elicit protein oligomerization over
time. However, from the results of this study, a decrease in fluorescence intensity was
observed. This reduction of fluorescence intensity is believed to be result of other means
of protein modification, such as adduct formation.

76

Table 3.1

RIFI of RNase A (0.050 mM) and RNase A (0.050 mM) modified by
HNQ (0.050, 0.10, 0.25, 0.50, or 1.5 mM) for 24 h at 37°C. Absorbance
at 346 nm of RNase A (0.050 mM) and RNase A (0.050 mM) modified by
HNQ (0.050, 0.10, 0.25, 0.50, or 1.5 mM) for 24 h at 37°C.
RIFIa (%)

RIFIb (%)

0

0

-0.002

RNase A + HNQ (0.050 mM)

11

11

0.029

RNase A + HNQ (0.10 mM)

32

31

0.057

RNase A + HNQ (0.25 mM)

47

46

0.088

RNase A + HNQ (0.50 mM)

90

91

0.283

RNase A + HNQ (1.5 mM)

97

98

1.035

Reaction
RNase A (0.050 mM)

a
b

A346 (a.u.)

integration between 290-400 nm
integration between 300-330 nm

Figure 3.1

Fluorescence spectra of RNase A (0.050 mM) and RNase A (0.050 mM)
modified by HNQ (0.050, 0.10, 0.25, 0.50, or 1.5 mM) for 24 h at 37°C.
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Figure 3.2

UV-VIS spectra of RNase A (0.050 mM) and RNase A (0.050 mM)
modified by HNQ (0.050, 0.10, 0.25, 0.50, or 1.5 mM) for 24 h at 37°C.

To quantify the degree of modification of Ribonuclease A, RIFI values were
calculated using RNase A (0.050 mM) as the reference NIFI. As seen in Table 3.1, the
RIFI increases as the concentration of HNQ in the reaction solution increases. This is
interpreted as an increase in the modification of Ribonuclease A upon exposure to
increasing concentration of HNQ. Considering all reactions performed in this study,
Table 3.1 shows no more than a 1% difference in RIFI values calculated over the two
integration ranges.
As seen in Figure 3.2, the absorbance in the 320-550 nm range increases as the
concentration of HNQ increases in the reaction solution. Since HNQ absorbs in this
range, and any free HNQ has already been removed through dialysis, the increase in
absorbance is believed to be result of HNQ covalently bonded to Ribonuclease A. To
78

monitor this, Table 3.1 shows the absorbance at 346 nm of Ribonuclease A and modified
Ribonuclease A. From these results, increasing the concentration of HNQ increases the
overall absorbance of modified Ribonuclease A. This is interpreted as an increase in the
modification of Ribonuclease A upon increasing concentration of HNQ.
In summary, Ribonuclease A modification was found to be increasing with the
concentration of HNQ. In addition to the SDS-PAGE data presented in Chapter 1 [Smith
& Kim, 2015], and similar to what was observed during previous studies with
Ribonuclease A, this study shows HNQ exhibits its modifying capabilities solely through
adduct formation.

3.3.2

Ribonuclease A Modifications Induced by HNQ at Various pH
In this study, RNase A (0.050 mM) was treated with HNQ (0.010 mM) at pH=6.0,

pH=7.0, and pH=8.0 and allowed to react while being monitored using fluorescence for
24 h. Following the 24 h incubation, dialysis was performed for an additional 24 h
followed by a final spectroscopic measurement of modified Ribonuclease A. All
reactions were performed in a phosphate buffer (50 mM) at 37°C.
Table 3.2 lists RIFI values calculated over 290-400 nm and 300-330 nm in
addition to absorbance values for each reaction performed in this study. Figure 3.3 shows
the fluorescence intensity of Ribonuclease A and Ribonuclease A modified by HNQ
(0.10 mM) at pH=6.0, pH=7.0, and pH=8.0 for 24 h at 37°C. All spectra were
normalized in the 500-550 nm range where little emission is present to ensure proper
comparison. Figure 3.4 shows the absorbance of Ribonuclease A and Ribonuclease A
modified by HNQ (0.10 mM) at pH=6.0, pH=7.0, and pH=8.0 for 24 h at 37°C.
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Table 3.2

RIFI of RNase A (0.050 mM) modified by HNQ (0.10 mM) at pH=6.0,
pH=7.0, and pH=8.0 for 24 h at 37°C. Absorbance at 346 nm of RNase A
(0.050 mM) modified by HNQ (0.10 mM) at pH=6.0, pH=7.0, and pH=8.0
for 24 h at 37°C.
RIFIa (%)

RIFIb (%)

RNase A + HNQ (0.10 mM) pH=6.0

-1

-2

0.048

RNase A + HNQ (0.10 mM) pH=7.0

0

0

0.057

RNase A + HNQ (0.10 mM) pH=8.0

52

53

0.109

Reaction

a
b

A346 (a.u.)

integration between 290-400 nm
integration between 300-330 nm

As seen in Figure 3.3, the fluorescence intensity decreases as the pH of the
reaction solution increases from 7.0 to 8.0 and remains much the same as the pH of the
reaction solution decreases from 7.0 to 6.0. This is believed to be due to increasing and
decreasing the nucleophilic character of the protein and therefore increasing and
decreasing the likelihood of association of Ribonuclease A and HNQ. In addition, since
protein oligomerization is not induced by HNQ, or influenced by pH changes, increasing
the pH of the reaction solution encourages other means of protein modification to occur,
such as adduct formation. To quantify this degree of modification of Ribonuclease A,
RIFI values were calculated using RNase A + HNQ (0.10 mM) pH=7.0 as the reference
NIFI. As seen in Table 3.2, the RIFI increases only as the pH of the reaction solution
increases from 7.0 to 8.0 and is found to have little change when the pH of the reaction
solution is decreased from 7.0 to 6.0. This is interpreted as an increase of modification of
Ribonuclease A only upon increasing the pH of the reaction solution.
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Fluorescence Intensity (a.u.)

80,000
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RNase A + HNQ (0.10 mM) pH=6.0

RNase A + HNQ (0.10 mM) pH=7.0
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RNase A + HNQ (0.10 mM) pH=8.0

20,000

0
280
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340
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400
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460

490

520
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Wavelength (nm)
Figure 3.3

Fluorescence spectra of RNase A (0.050 mM) modified by HNQ (0.10
mM) at pH=6.0, pH=7.0, and pH=8.0 for 24 h at 37°C.

Obviously, incubating Ribonuclease A with HNQ regardless of the pH causes a
modification of Ribonuclease A. However, considering conditions at physiological pH,
an increase in pH causes greater modification of Ribonuclease A and a decrease in pH
causes little to no change in the modification of Ribonuclease A. Considering all
reactions performed in this study, Table 3.2 shows no more than a 1% difference in RIFI
values calculated over the two integration ranges.
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RNase A + HNQ (0.10 mM) pH=8.0

1.0

RNase A + HNQ (0.10 mM) pH=7.0

0.8

RNase A + HNQ (0.10 mM) pH=6.0

0.5

0.3

0.0
200

300

400

500

600

700

Wavelength (nm)
Figure 3.4

UV-VIS spectra of RNase A (0.050 mM) modified by HNQ (0.10 mM) at
pH=6.0, pH=7.0, and pH=8.0 for 24 h at 37°C.

As seen in Figure 3.4, the absorbance in the 320-550 nm range increases as the
pH of the reaction solution increases from 7.0 to 8.0 and decreases slightly as the pH of
the reaction solution decreases from 7.0 to 6.0. Since HNQ absorbs in this range, and any
free HNQ has already been removed through dialysis, the increase and decrease in
absorbance is believed to be result of HNQ covalently bonded to Ribonuclease A. To
monitor this, Table 3.2 shows the absorbance at 346 nm of Ribonuclease A incubated
with HNQ at pH=6.0, pH=7.0, and pH=8.0. From these results, increasing the pH of the
reaction solution from 7.0 to 8.0 increases the absorbance and decreasing the pH of the
reaction solution from 7.0 to 6.0 decreases the absorbance. Again, any incubation of
Ribonuclease A with HNQ will cause an increase in the overall absorbance of

82

Ribonuclease A, however, in this study, comparisons to physiological pH were made, and
increases and decreases in absorbance were noted as result.
Considering the results of this study, several assumptions can be made. For
example, increasing the pH of solution gives rise to increasing deprotonation of
Ribonuclease A which results in greater attractive forces between HNQ and Ribonuclease
A. In addition, because the pKa of the hydrogen on hydroxyl group of HNQ is 4.3, HNQ
assumes a negative partial charge in all incubations at pH=6.0, pH=7.0, and pH=8.0
[Scifinder]. This would result in greater association of HNQ to positively charged amino
acid residues of Ribonuclease A upon increasing the pH and less association of HNQ to
positively charged amino acid residues of Ribonuclease A upon decreasing the pH. In
contrast, decreasing the pH of solution gives rise to increasing protonation of HNQ and
Ribonuclease A which would result in greater repulsive forces and lessen the interaction
between the two. Although Figure 3.3 does not show a large increase in fluorescence
spectroscopy of the reaction RNase A + HNQ (0.10 mM) pH=6.0, Figure 3.4 does show
slight differences between the reactions performed at pH=6.0 and pH=7.0. Because UVVIS spectroscopy is believed to detect changes due to adduct formation, the reaction
performed at pH=6.0 shows supporting results of less modification due to greater
amounts of HNQ and Ribonuclease A repelling one another as result of protonation
caused by the lower pH.
In summary, Ribonuclease A modification was found to be increasing with
respect to increasing the pH of the reaction solution from 7.0 to 8.0 and unchanged when
decreasing the pH of the reaction solution from 7.0 to 6.0. In addition to SDS-PAGE
data presented in Chapter 1 [Smith & Kim, 2015], this study shows HNQ exhibits its
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modifying capabilities solely through adduct formation and is largely unaffected by
decreases in pH.

3.4 Conclusions

Ribonuclease A modifications were observed with HNQ incubations as well as
when environmental conditions were altered. Ribonuclease A modification, through
adduct formation, was found to be increasing with the concentration of HNQ. In
addition, Ribonuclease A modification was found to be increasing with respect to
increasing the pH of the reaction solution from 7.0 to 8.0 and unchanged when decreasing
the pH of the reaction solution from 7.0 to 6.0. In support of previous studies [Smith &
Kim, 2015], HNQ was observed to exhibit its protein modifying capabilities solely
through adduct formation and does not produce protein oligomerization.
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APPENDIX A

Anisotropy measures the non-sphericity of a molecule by recording the amount of
emitted light that passes through different polarized planes. In these studies, larger
values of anisotropy correspond to Lysozyme that has been modified resulting in
polymerization or an overall non-spherical shape, while smaller values of anisotropy
correspond to Lysozyme that has been modified resulting in an increased spherical shape.
Anisotropy values of post-dialysis Lysozyme recorded from 300-450 nm
corresponding to each of the six different studies performed are presented in the
following pages. These values were averaged and general trends in anisotropy were
observed as result.
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Figure A.1

Anisotropy values recorded from 300-450 nm with an average anisotropy
value of Lyz (0.010 mM) and Lyz (0.010 mM) modified by PBQ (0.010,
0.050, 0.10, or 0.30 mM) for 24 h at 37°C.

A general trend of increasing anisotropy with increasing concentration of PBQ is
observed. These results suggest PBQ alters the structure of Lysozyme by
oligomerization and adduct formation resulting in an overall non-spherical shape of the
protein.
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Lyz (0.010 mM)
Lyz (0.010 mM) 0 hr
Lyz + PBQ (0.050 mM) 0 hr
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Figure A.2

Anisotropy values recorded from 300-450 nm with an average anisotropy
value of Lyz (0.010 mM) and Lyz (0.010 mM) modified by PBQ (0.050
mM) for 0 h, 1 h, 2 h, 3 h, and 24 h at pH=7.0 and 37°C.

These results suggest the overall sphericity of Lysozyme increases upon initial
exposure to PBQ and becomes non-spherical after several hours of incubation.
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Figure A.3

Anisotropy values recorded from 300-450 nm with an average anisotropy
value of Lyz (0.010 mM) and Lyz (0.010 mM) modified by MBQ (0.050
mM), PBQ (0.050 mM), PhBQ (0.050 mM), CBQ (0.050 mM), and
TCBQ (0.050 mM) for 24 h at 37°C.

A general trend of increasing anisotropy with increasing electron withdrawing
capability of each substituted quinone is observed. These results suggest substituted
quinones alter the structure of Lysozyme by oligomerization and adduct formation
resulting in an overall non-spherical shape of the protein. Consistent with Figures 2.5
and 2.6, PhBQ modifies Lysozyme in a way that increases the sphericity of the protein.
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Figure A.4

Anisotropy values recorded from 300-450 nm with an average anisotropy
value of Lyz (0.010 mM) and Lyz (0.010 mM) modified by HNQ (0.050
mM), PNQ (0.050 mM), and ONQ (0.050 mM) for 24 h at 37°C.

The results of these studies indicate naphthoquinones modify Lysozyme resulting
in an increased spherical shape of the protein. Specifically, with support of Figures 2.7
and 2.8, ONQ elicits the largest degree of modification and is shown to modify
Lysozyme in a way that increases the sphericity of the protein.
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Figure A.5

Anisotropy values recorded from 300-450 nm with an average anisotropy
value of Lyz (0.010 mM) modified by PBQ (0.050 mM) at pH=6.0,
pH=7.0, and pH=8.0 for 24 h at 37°C.

A general trend of increasing anisotropy with increasing pH of reaction solution is
observed. These results suggest increasing the pH of the reaction solution influences the
modification of PBQ resulting in an overall non-spherical shape of the protein. In
contrast, decreasing the pH of the reaction solution influences the modification of PBQ
resulting in an increased spherical shape of the protein.
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Figure A.6

Anisotropy values recorded from 300-450 nm with an average anisotropy
value of Lyz (0.010 mM) modified by PBQ (0.050 mM) at 27°C, 37°C,
and 42°C for 24 h at pH=7.0.

A general trend of increasing anisotropy with increasing temperature of reaction
solution is observed. These results suggest increasing the temperature of the reaction
solution influences the modification of PBQ resulting in an overall non-spherical shape of
the protein. In contrast, decreasing the temperature of the reaction solution influences the
modification of PBQ resulting in an increased spherical shape of the protein.
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APPENDIX B

Anisotropy measures the non-sphericity of a molecule by recording the amount of
emitted light that passes through different polarized planes. In these studies, larger
values of anisotropy correspond to Ribonuclease A that has been modified resulting in an
overall non-spherical shape, while smaller values of anisotropy correspond to
Ribonuclease A that has been modified resulting in an increased spherical shape.
Anisotropy values of post-dialysis Ribonuclease A recorded from 300-450 nm
corresponding to the different studies performed are presented in the following pages.
These values were averaged and general trends in anisotropy were observed as result.
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Figure B.1

Anisotropy values recorded from 300-450 nm with an average anisotropy
value of RNase A (0.050 mM) and RNase A (0.050 mM) modified by
HNQ (0.050, 0.10, 0.25, 0.50, or 1.5 mM) for 24 h at 37°C.

The results of these studies display no clear trend of increasing or decreasing
anisotropy with increasing concentration of HNQ. This suggests HNQ does not modify
Ribonuclease A in a consistent manner in regard to HNQ concentration.
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Figure B.2

Anisotropy values recorded from 300-450 nm with an average anisotropy
value of RNase A (0.050 mM) modified by HNQ (0.10 mM) at pH=6.0,
pH=7.0, and pH=8.0 for 24 h at 37°C.

The results of these studies display no clear trend of increasing or decreasing
anisotropy with changes in pH. Similar to the studies performed with Lysozyme,
increasing the pH of the reaction solution causes an overall increased non-spherical shape
of Ribonuclease A. However, regarding decreases in the pH of the reaction solution,
these results do not follow a similar trend as seen in Figure A.5.
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APPENDIX C

Pre-dialysis and post-dialysis fluorescence scans of Lysozyme (incubated with
PBQ) and Ribonuclease A (incubated with HNQ) from 290-600 nm are presented below.
These scans are non-normalized and reflect the changes in fluorescence intensity over the
initial 24 h incubation with quinone. The post-dialysis fluorescence scans are represented
by the dark blue line denoted “AD”.
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Figure C.1

Pre-dialysis and post-dialysis fluorescence scans of Lyz + PBQ (0.050
mM) for 24 h at 37°C.
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Figure C.2

Pre-dialysis and post-dialysis fluorescence scans of RNase A + HNQ (0.10
mM) for 24 h at 37°C. (The apparent increase of fluorescence intensity of
post-dialysis RNase A is representative of initial fluorescence quenching
by the concentrated HNQ solution.)
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